data_2mva_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mva _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.642 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 10.3 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.945 0.403 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -83.24 13.41 4.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.793 -174.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.66 -77.01 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.996 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.642 ' O ' ' HB2' ' A' ' 5' ' ' CYS . 8.4 p -77.14 159.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.4 m -102.25 117.5 34.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.723 0.296 . . . . 0.0 110.685 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.1 m -79.24 127.28 79.55 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.12 0.486 . . . . 0.0 110.528 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.564 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 19.4 Cg_endo -58.28 -26.58 77.49 Favored 'Trans proline' 0 N--CA 1.474 0.351 0 C-N-CA 124.077 3.185 . . . . 0.0 113.554 -177.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.547 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 23.2 t -131.73 165.12 24.45 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.38 50.54 4.08 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.712 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.733 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -94.94 -118.58 0.1 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 122.735 -0.274 . . . . 0.0 111.447 175.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -134.23 159.14 41.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.09 0.471 . . . . 0.0 110.78 -176.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.3 m -101.08 95.89 6.87 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.582 -173.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.465 ' CB ' HG22 ' A' ' 24' ' ' ILE . 7.9 p -78.95 51.94 1.19 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.54 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 45.3 mm -62.14 -18.7 20.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.242 0.544 . . . . 0.0 111.279 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.22 -36.97 21.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.438 0.637 . . . . 0.0 110.684 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 29.7 t70 -91.09 -48.94 6.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.105 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 15.6 pttm -159.53 -138.81 0.06 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.197 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -92.09 -77.5 0.43 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.172 0.51 . . . . 0.0 110.163 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 77.0 m -121.92 143.24 49.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.377 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.465 HG22 ' CB ' ' A' ' 17' ' ' SER . 1.3 pp -80.05 -15.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -175.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.733 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 13.8 mptt 55.84 29.29 13.77 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.51 ' HD3' ' C ' ' A' ' 26' ' ' LYS . 8.6 tmtm? -91.31 106.11 18.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.218 0.532 . . . . 0.0 109.809 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.44 178.645 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -98.61 136.65 38.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.182 0.515 . . . . 0.0 110.711 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.75 -146.81 4.73 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.423 HG13 ' H ' ' A' ' 9' ' ' THR . 5.9 p -74.27 -63.27 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 117.028 0.414 . . . . 0.0 110.47 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.423 ' H ' HG13 ' A' ' 8' ' ' VAL . 57.2 m -156.18 81.01 0.99 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.068 0.461 . . . . 0.0 110.53 177.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.1 m -124.96 127.65 25.04 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.54 167.24 25.93 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.022 1.815 . . . . 0.0 110.992 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.9 m -94.91 38.08 1.13 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.715 0.769 . . . . 0.0 110.644 -173.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.55 -51.66 2.47 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.451 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.631 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -105.55 -104.54 0.32 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.482 0.179 . . . . 0.0 111.482 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.442 ' H ' HD12 ' A' ' 24' ' ' ILE . 18.2 ptp180 -152.6 169.43 22.68 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.444 ' HB2' HG12 ' A' ' 18' ' ' ILE . 31.8 p -98.19 126.89 43.85 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 t -102.6 40.35 1.38 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.712 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.444 HG12 ' HB2' ' A' ' 16' ' ' CYS . 34.7 mm -62.03 -21.3 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.5 -171.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.0 m -77.7 -37.01 23.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.238 0.542 . . . . 0.0 110.905 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.483 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 11.9 t70 -91.97 -47.03 7.51 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.677 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HG2' ' OD2' ' A' ' 20' ' ' ASP . 15.5 pttm -160.36 -146.52 0.14 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.753 -176.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.451 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 29.1 tt0 -68.89 -85.7 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.338 0.589 . . . . 0.0 111.011 172.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.451 ' SG ' ' HG2' ' A' ' 22' ' ' GLN . 3.2 m -132.64 171.17 14.19 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.442 HD12 ' H ' ' A' ' 15' ' ' ARG . 1.0 OUTLIER -96.7 -13.48 8.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -176.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.631 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 14.5 mptt 55.09 30.93 15.24 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 123.38 0.425 . . . . 0.0 111.651 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -79.31 81.0 5.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.309 -177.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.504 179.437 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 121.375 0.607 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 62.41 27.47 16.35 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.798 171.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.96 -64.7 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.0 t -90.54 135.77 25.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 175.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 m -89.43 105.07 17.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.101 0.476 . . . . 0.0 110.703 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.4 m -80.96 138.94 49.57 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.075 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.471 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 18.0 Cg_endo -58.09 -23.64 62.05 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 124.064 3.176 . . . . 0.0 112.931 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.7 m -136.71 159.86 40.56 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.15 49.01 3.91 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.555 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.763 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -90.45 -105.98 0.09 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.588 0.232 . . . . 0.0 111.516 175.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -132.66 148.47 52.35 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 77.0 m -91.94 111.57 23.16 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.502 ' HB2' HG21 ' A' ' 24' ' ' ILE . 11.5 t -87.05 50.34 2.0 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.121 -174.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.6 mm -65.34 -17.09 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.963 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.3 m -78.39 -38.04 22.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.704 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.452 ' HB2' ' OG ' ' A' ' 17' ' ' SER . 12.9 m-20 -90.98 -67.19 0.87 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.681 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.456 ' HB2' ' H ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -143.2 -124.83 0.09 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.473 -177.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.456 ' H ' ' HB2' ' A' ' 21' ' ' LYS . 20.5 pt20 -93.23 -57.73 2.52 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.975 0.807 . . . . 0.0 111.904 174.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.405 ' N ' ' HG3' ' A' ' 22' ' ' GLN . 60.8 m -139.26 154.44 47.97 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -174.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.502 HG21 ' HB2' ' A' ' 17' ' ' SER . 1.0 OUTLIER -87.84 -18.32 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -173.335 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.763 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 46.7 54.75 8.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.895 0.379 . . . . 0.0 110.873 -174.179 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -152.95 128.43 9.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.09 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.55 178.257 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.456 -0.156 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -80.1 57.55 2.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.783 0.801 . . . . 0.0 109.775 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.61 -71.94 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.7 t -91.58 118.53 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.3 m -82.34 130.94 35.21 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.965 0.412 . . . . 0.0 110.794 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.3 m -84.79 153.96 61.11 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.795 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 6.9 Cg_endo -48.84 -71.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.261 2.641 . . . . 0.0 112.494 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.51 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 33.0 m -86.92 163.28 17.23 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.72 51.68 3.27 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.54 -175.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.772 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -88.32 -100.97 0.08 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 121.343 -0.143 . . . . 0.0 111.349 176.42 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -148.42 153.79 39.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.129 0.49 . . . . 0.0 110.659 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.3 m -93.91 95.61 9.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.161 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.478 ' CB ' HG22 ' A' ' 24' ' ' ILE . 5.6 p -82.11 45.23 0.91 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.115 -177.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.2 mm -56.68 -16.28 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.365 0.602 . . . . 0.0 111.727 -173.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.1 m -77.58 -36.99 23.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.419 0.628 . . . . 0.0 110.139 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -91.04 -74.74 0.49 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.303 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -148.97 160.37 43.35 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -39.36 -57.98 1.3 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -168.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 33.7 m -136.38 140.56 43.32 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.49 HD12 ' HB2' ' A' ' 14' ' ' TYR . 1.3 pp -78.86 -16.59 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -175.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.772 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 52.98 35.03 18.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.944 -176.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.36 101.32 13.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.891 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 121.95 0.881 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -153.27 44.18 0.62 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.5 -174.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.25 -45.22 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.726 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.4 t -90.08 104.34 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.702 0.287 . . . . 0.0 110.462 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.5 m -79.89 90.12 5.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.904 ' SG ' ' HD2' ' A' ' 11' ' ' PRO . 4.5 t -92.17 155.9 42.43 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.125 -172.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.904 ' HD2' ' SG ' ' A' ' 10' ' ' CYS . 7.4 Cg_endo -45.3 -74.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 123.941 3.094 . . . . 0.0 112.873 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.635 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 46.8 t -84.4 150.89 25.03 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.15 52.12 4.32 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.931 -176.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.809 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -81.5 -100.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.816 176.16 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.436 ' H ' HD12 ' A' ' 24' ' ' ILE . 15.3 ptp180 -154.79 160.74 41.49 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.1 p -104.2 104.26 14.15 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.445 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 7.9 p -78.99 59.94 2.79 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.97 -174.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.8 mm -55.01 -18.12 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.278 0.561 . . . . 0.0 111.12 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.8 m -78.59 -39.38 23.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.641 0.734 . . . . 0.0 110.808 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.488 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 16.0 t70 -93.41 -71.21 0.67 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.518 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.488 ' HG2' ' OD2' ' A' ' 20' ' ' ASP . 23.0 pttm -156.75 178.1 10.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.502 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -46.02 -49.21 16.43 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 65.6 m -149.74 154.51 38.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.268 0.556 . . . . 0.0 110.211 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.436 HD12 ' H ' ' A' ' 15' ' ' ARG . 0.8 OUTLIER -90.04 -25.25 5.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.814 -173.122 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.809 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 53.71 37.92 27.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.887 -171.079 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -117.16 171.95 7.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.666 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.003 179.156 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.1 t . . . . . 0 C--O 1.236 0.356 0 CA-C-O 121.151 0.5 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -155.62 66.86 0.62 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.327 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.5 -83.44 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.388 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -73.48 120.47 22.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.9 m -79.55 109.19 13.69 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.351 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.2 m -79.88 139.69 53.94 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.008 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.438 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 13.3 Cg_endo -55.8 -69.42 0.05 OUTLIER 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.929 2.419 . . . . 0.0 112.425 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.461 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 3.4 m -81.61 165.97 20.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.242 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.17 45.3 2.99 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.93 -174.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.645 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -89.03 -104.44 0.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.557 0.218 . . . . 0.0 111.336 177.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.44 ' HG3' ' CG1' ' A' ' 24' ' ' ILE . 2.0 ptm180 -148.25 156.26 42.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.888 0.375 . . . . 0.0 110.517 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.2 m -89.32 108.45 19.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.768 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.453 ' HB2' HG22 ' A' ' 24' ' ' ILE . 5.8 t -82.63 52.77 2.17 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 30.9 mm -64.99 -16.06 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.378 0.609 . . . . 0.0 110.593 -175.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 m -78.06 -36.99 22.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.526 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.409 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 28.4 t70 -90.97 -55.0 3.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.75 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 15.4 pttm -155.32 -123.53 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.768 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.22 -65.84 0.97 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.231 0.539 . . . . 0.0 110.908 176.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.5 m -136.9 155.47 49.72 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -175.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.453 HG22 ' HB2' ' A' ' 17' ' ' SER . 0.8 OUTLIER -85.97 -14.53 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -175.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.645 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 52.08 47.45 24.73 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.082 -176.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.438 ' HG2' ' HB ' ' A' ' 24' ' ' ILE . 74.3 mmtt -80.82 62.61 4.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.139 0.495 . . . . 0.0 110.267 175.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.338 -0.839 . . . . 0.0 109.807 -178.942 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.233 0.203 0 CA-C-O 121.552 0.691 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -92.31 24.32 3.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.52 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.59 141.88 8.3 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.9 t -79.77 81.05 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.48 0.657 . . . . 0.0 110.487 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 t -115.11 31.35 6.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 122.232 1.015 . . . . 0.0 109.214 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.3 m -140.76 140.06 21.18 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.533 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.465 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 15.0 Cg_endo -56.54 -25.29 57.97 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 124.186 3.257 . . . . 0.0 112.893 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.7 m -139.45 155.58 47.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.394 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.4 45.16 3.34 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.351 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.708 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -80.02 -96.7 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.436 -0.106 . . . . 0.0 111.221 177.294 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.412 ' O ' HG13 ' A' ' 24' ' ' ILE . 71.9 mtm180 -137.62 130.62 30.37 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.195 0.522 . . . . 0.0 111.06 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.438 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 22.5 m -86.62 84.92 7.3 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.678 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.469 ' CB ' HG23 ' A' ' 24' ' ' ILE . 26.5 p -78.99 44.62 0.57 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.721 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.6 mm -64.32 -18.3 22.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 121.722 0.772 . . . . 0.0 110.329 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 m -78.24 -33.37 17.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.415 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -87.93 -52.91 5.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.421 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -160.94 -127.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.338 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -83.23 -134.81 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.457 ' SG ' ' HE1' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -94.31 154.66 17.39 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.469 HG23 ' CB ' ' A' ' 17' ' ' SER . 1.6 pp -79.65 -9.49 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -168.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.708 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 1.9 mptm? 43.74 60.74 2.55 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 24' ' ' ILE . 47.0 mmtm -125.53 51.99 1.67 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.92 0.391 . . . . 0.0 111.057 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.545 176.672 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 16' ' ' CYS . 3.6 t . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 54.34 56.44 6.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.529 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.94 121.23 1.01 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.418 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.9 m -91.19 -22.0 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.186 0.517 . . . . 0.0 110.59 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 m -88.18 75.61 8.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.885 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 68.9 m -151.34 111.22 3.01 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.618 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.539 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 18.6 Cg_endo -58.49 -31.51 94.43 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.189 2.593 . . . . 0.0 112.57 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.477 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 24.0 m -126.18 160.38 30.38 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.64 48.62 3.08 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.549 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.539 ' OH ' ' HG2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -84.38 -97.74 0.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.469 0.174 . . . . 0.0 111.469 177.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 24' ' ' ILE . 77.7 mtm180 -136.0 133.47 37.53 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.497 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 57.0 m -86.2 93.21 8.99 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.651 -171.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.522 ' HB2' HG22 ' A' ' 24' ' ' ILE . 7.8 t -79.94 47.82 0.91 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.304 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 42.2 mm -66.08 -17.44 22.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.76 0.79 . . . . 0.0 109.832 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.4 m -77.95 -35.34 20.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.894 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -91.47 -49.57 6.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.16 0.505 . . . . 0.0 110.676 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.52 ' HE3' ' O ' ' A' ' 23' ' ' CYS . 47.5 pttt -157.02 -121.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.804 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.418 ' HG3' ' H ' ' A' ' 23' ' ' CYS . 5.9 pt20 -91.66 -70.98 0.66 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.459 -0.151 . . . . 0.0 111.177 173.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.52 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -148.2 166.05 29.1 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.025 -0.422 . . . . 0.0 110.406 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.522 HG22 ' HB2' ' A' ' 17' ' ' SER . 1.4 pp -91.15 -3.58 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -167.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.539 ' HB3' ' HZ1' ' A' ' 25' ' ' LYS . 3.6 mmmp? 51.93 31.77 9.0 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 177.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.423 ' HB2' HD13 ' A' ' 24' ' ' ILE . 48.1 mmtm -111.9 85.73 2.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.118 0.485 . . . . 0.0 110.056 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 . . . . . 0 C--O 1.25 1.09 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.263 -176.779 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.0 t . . . . . 0 N--CA 1.458 -0.047 0 CA-C-O 121.066 0.46 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -122.29 2.08 9.7 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.883 0.849 . . . . 0.0 109.714 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.86 98.41 0.18 Allowed Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.018 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.8 t -76.37 77.42 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.429 0.633 . . . . 0.0 111.293 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.7 t -99.33 25.05 7.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.331 1.063 . . . . 0.0 108.992 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 18.6 m -107.07 140.83 21.8 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.795 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.94 -27.2 84.38 Favored 'Trans proline' 0 N--CA 1.474 0.328 0 C-N-CA 124.08 3.187 . . . . 0.0 112.912 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.0 t -134.47 158.27 44.35 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.55 46.98 3.54 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.083 -173.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.536 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -82.43 -102.71 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.975 174.705 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.435 ' HG3' HG12 ' A' ' 24' ' ' ILE . 15.9 ptm180 -143.63 159.14 42.99 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.3 m -106.92 93.35 4.51 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.434 ' CB ' HG21 ' A' ' 24' ' ' ILE . 4.8 p -79.9 42.8 0.56 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.13 -175.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.2 mm -55.13 -19.16 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.427 0.632 . . . . 0.0 110.909 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.5 m -77.5 -38.18 25.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.767 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.501 ' OD2' ' HD2' ' A' ' 21' ' ' LYS . 37.3 t70 -92.59 -71.02 0.67 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.207 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.501 ' HD2' ' OD2' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -149.3 157.42 43.32 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 172.176 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -38.72 -53.68 1.63 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -165.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.6 m -139.6 146.89 40.36 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.936 -0.477 . . . . 0.0 110.893 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.453 HD12 ' HB2' ' A' ' 14' ' ' TYR . 1.4 pp -84.69 -9.99 11.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -174.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.536 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 9.7 mptt 61.47 20.34 11.09 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.432 ' HB2' HD13 ' A' ' 24' ' ' ILE . 14.5 mmmm -98.28 81.6 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.76 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 C--O 1.25 1.112 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.405 178.961 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -111.88 62.25 0.62 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.593 0.711 . . . . 0.0 109.772 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.61 64.73 2.81 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.894 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.6 p -69.83 -16.8 20.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.347 0.594 . . . . 0.0 110.946 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.4 t -122.67 31.03 6.22 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.332 1.063 . . . . 0.0 109.205 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 37.0 m -135.77 142.4 40.54 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.509 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.45 -3.68 6.86 Favored 'Trans proline' 0 N--CA 1.475 0.431 0 C-N-CA 123.527 2.818 . . . . 0.0 113.514 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 t 56.04 32.52 20.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.864 0.84 . . . . 0.0 111.364 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.25 -46.79 3.72 Favored Glycine 0 C--N 1.316 -0.555 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.025 176.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.707 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -91.34 -101.16 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.663 -0.268 . . . . 0.0 111.088 176.223 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.426 ' H ' ' HD1' ' A' ' 14' ' ' TYR . 12.0 ptm180 -161.4 175.43 12.22 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.562 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 3.7 p -109.78 103.24 12.02 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.168 0.508 . . . . 0.0 110.178 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.8 p -79.16 59.87 2.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.044 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 38.7 mm -62.8 -15.94 16.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.789 0.804 . . . . 0.0 110.113 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.7 m -77.5 -34.92 21.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.549 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -91.98 -55.81 3.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.154 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 11.6 pttp -154.79 -126.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.22 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.414 ' HG3' ' H ' ' A' ' 23' ' ' CYS . 3.0 pt20 -91.37 -58.56 2.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 118.422 0.556 . . . . 0.0 111.004 174.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.562 ' SG ' ' HA ' ' A' ' 16' ' ' CYS . 9.4 m -148.67 159.86 43.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.054 0.454 . . . . 0.0 110.378 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.511 ' HB ' ' HG2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -90.89 -11.29 9.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -168.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.707 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 31.3 mmmt 55.28 34.72 23.38 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.511 ' HG2' ' HB ' ' A' ' 24' ' ' ILE . 74.9 mmtt -81.04 71.31 8.01 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.24 0.543 . . . . 0.0 110.361 176.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.848 -177.386 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 66.0 tp . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.408 0.147 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -103.15 27.27 7.34 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.559 -174.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.429 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 62.2 t30 -66.78 -50.74 42.96 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 175.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 3' ' ' ASN . 43.3 Cg_endo -69.45 140.98 45.23 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.783 1.655 . . . . 0.0 110.742 168.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.642 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 10.3 m -59.76 137.95 57.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.057 -174.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -83.24 13.41 4.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.793 -174.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.66 -77.01 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.996 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.642 ' O ' ' HB2' ' A' ' 5' ' ' CYS . 8.4 p -77.14 159.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.4 m -102.25 117.5 34.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.723 0.296 . . . . 0.0 110.685 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.1 m -79.24 127.28 79.55 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.12 0.486 . . . . 0.0 110.528 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.564 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 19.4 Cg_endo -58.28 -26.58 77.49 Favored 'Trans proline' 0 N--CA 1.474 0.351 0 C-N-CA 124.077 3.185 . . . . 0.0 113.554 -177.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.547 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 23.2 t -131.73 165.12 24.45 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.38 50.54 4.08 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.712 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.733 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -94.94 -118.58 0.1 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 122.735 -0.274 . . . . 0.0 111.447 175.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -134.23 159.14 41.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.09 0.471 . . . . 0.0 110.78 -176.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.3 m -101.08 95.89 6.87 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.582 -173.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.465 ' CB ' HG22 ' A' ' 24' ' ' ILE . 7.9 p -78.95 51.94 1.19 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.54 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 45.3 mm -62.14 -18.7 20.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.242 0.544 . . . . 0.0 111.279 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.22 -36.97 21.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.438 0.637 . . . . 0.0 110.684 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 29.7 t70 -91.09 -48.94 6.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.105 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 15.6 pttm -159.53 -138.81 0.06 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.197 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -92.09 -77.5 0.43 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.172 0.51 . . . . 0.0 110.163 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 77.0 m -121.92 143.24 49.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.377 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.465 HG22 ' CB ' ' A' ' 17' ' ' SER . 1.3 pp -80.05 -15.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -175.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.733 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 13.8 mptt 55.84 29.29 13.77 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.51 ' HD3' ' C ' ' A' ' 26' ' ' LYS . 8.6 tmtm? -91.31 106.11 18.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.218 0.532 . . . . 0.0 109.809 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.44 178.645 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.585 ' HA ' ' O ' ' A' ' 12' ' ' SER . 6.8 t30 58.4 63.13 1.79 Allowed 'General case' 0 N--CA 1.463 0.201 0 O-C-N 123.621 0.576 . . . . 0.0 110.608 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -103.87 106.14 51.43 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.171 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -74.48 68.26 5.32 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.99 2.46 . . . . 0.0 111.651 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.3 t -93.89 145.93 24.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.201 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -98.61 136.65 38.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.182 0.515 . . . . 0.0 110.711 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.75 -146.81 4.73 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.423 HG13 ' H ' ' A' ' 9' ' ' THR . 5.9 p -74.27 -63.27 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 117.028 0.414 . . . . 0.0 110.47 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.423 ' H ' HG13 ' A' ' 8' ' ' VAL . 57.2 m -156.18 81.01 0.99 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.068 0.461 . . . . 0.0 110.53 177.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.1 m -124.96 127.65 25.04 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.54 167.24 25.93 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.022 1.815 . . . . 0.0 110.992 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 20.9 m -94.91 38.08 1.13 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.715 0.769 . . . . 0.0 110.644 -173.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.55 -51.66 2.47 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.451 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.631 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -105.55 -104.54 0.32 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.482 0.179 . . . . 0.0 111.482 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.442 ' H ' HD12 ' A' ' 24' ' ' ILE . 18.2 ptp180 -152.6 169.43 22.68 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.444 ' HB2' HG12 ' A' ' 18' ' ' ILE . 31.8 p -98.19 126.89 43.85 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 t -102.6 40.35 1.38 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.712 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.444 HG12 ' HB2' ' A' ' 16' ' ' CYS . 34.7 mm -62.03 -21.3 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.5 -171.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.0 m -77.7 -37.01 23.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.238 0.542 . . . . 0.0 110.905 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.483 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 11.9 t70 -91.97 -47.03 7.51 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.677 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HG2' ' OD2' ' A' ' 20' ' ' ASP . 15.5 pttm -160.36 -146.52 0.14 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.753 -176.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.451 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 29.1 tt0 -68.89 -85.7 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.338 0.589 . . . . 0.0 111.011 172.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.451 ' SG ' ' HG2' ' A' ' 22' ' ' GLN . 3.2 m -132.64 171.17 14.19 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.442 HD12 ' H ' ' A' ' 15' ' ' ARG . 1.0 OUTLIER -96.7 -13.48 8.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -176.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.631 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 14.5 mptt 55.09 30.93 15.24 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 123.38 0.425 . . . . 0.0 111.651 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -79.31 81.0 5.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.309 -177.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.504 179.437 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -128.14 86.14 2.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.264 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -128.1 78.01 75.95 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.957 0.408 . . . . 0.0 110.703 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.68 93.55 1.02 Allowed 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.543 2.162 . . . . 0.0 112.037 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.4 p -74.82 -25.11 58.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.375 0.607 . . . . 0.0 110.325 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 62.41 27.47 16.35 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.798 171.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.96 -64.7 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.0 t -90.54 135.77 25.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 175.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 m -89.43 105.07 17.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.101 0.476 . . . . 0.0 110.703 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.4 m -80.96 138.94 49.57 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.075 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.471 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 18.0 Cg_endo -58.09 -23.64 62.05 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 124.064 3.176 . . . . 0.0 112.931 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.7 m -136.71 159.86 40.56 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.15 49.01 3.91 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.555 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.763 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -90.45 -105.98 0.09 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.588 0.232 . . . . 0.0 111.516 175.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -132.66 148.47 52.35 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 77.0 m -91.94 111.57 23.16 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.502 ' HB2' HG21 ' A' ' 24' ' ' ILE . 11.5 t -87.05 50.34 2.0 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.121 -174.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.6 mm -65.34 -17.09 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.963 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.3 m -78.39 -38.04 22.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.704 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.452 ' HB2' ' OG ' ' A' ' 17' ' ' SER . 12.9 m-20 -90.98 -67.19 0.87 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.681 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.456 ' HB2' ' H ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -143.2 -124.83 0.09 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.473 -177.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.456 ' H ' ' HB2' ' A' ' 21' ' ' LYS . 20.5 pt20 -93.23 -57.73 2.52 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.975 0.807 . . . . 0.0 111.904 174.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.405 ' N ' ' HG3' ' A' ' 22' ' ' GLN . 60.8 m -139.26 154.44 47.97 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -174.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.502 HG21 ' HB2' ' A' ' 17' ' ' SER . 1.0 OUTLIER -87.84 -18.32 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -173.335 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.763 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 46.7 54.75 8.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.895 0.379 . . . . 0.0 110.873 -174.179 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -152.95 128.43 9.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.09 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.55 178.257 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 120.707 0.289 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -66.25 137.59 57.06 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.165 0.507 . . . . 0.0 111.091 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -130.86 150.31 76.17 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.887 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.41 172.86 14.63 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.5 2.133 . . . . 0.0 111.439 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 30.1 t -66.7 -29.8 69.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -80.1 57.55 2.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.783 0.801 . . . . 0.0 109.775 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.61 -71.94 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.7 t -91.58 118.53 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.3 m -82.34 130.94 35.21 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.965 0.412 . . . . 0.0 110.794 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.3 m -84.79 153.96 61.11 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.795 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 6.9 Cg_endo -48.84 -71.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.261 2.641 . . . . 0.0 112.494 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.51 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 33.0 m -86.92 163.28 17.23 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.72 51.68 3.27 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.54 -175.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.772 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -88.32 -100.97 0.08 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 121.343 -0.143 . . . . 0.0 111.349 176.42 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -148.42 153.79 39.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.129 0.49 . . . . 0.0 110.659 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.3 m -93.91 95.61 9.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.161 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.478 ' CB ' HG22 ' A' ' 24' ' ' ILE . 5.6 p -82.11 45.23 0.91 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.115 -177.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.2 mm -56.68 -16.28 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.365 0.602 . . . . 0.0 111.727 -173.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.1 m -77.58 -36.99 23.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.419 0.628 . . . . 0.0 110.139 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -91.04 -74.74 0.49 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.303 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -148.97 160.37 43.35 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -39.36 -57.98 1.3 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -168.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 33.7 m -136.38 140.56 43.32 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.49 HD12 ' HB2' ' A' ' 14' ' ' TYR . 1.3 pp -78.86 -16.59 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -175.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.772 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 52.98 35.03 18.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.944 -176.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.36 101.32 13.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.891 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.397 0.141 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 58.2 t30 57.61 65.25 1.37 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.694 0.759 . . . . 0.0 109.653 -176.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -126.9 100.55 27.5 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.422 -176.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.38 0.95 9.26 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.979 2.453 . . . . 0.0 111.128 174.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.7 t 71.04 118.57 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.245 -1.343 . . . . 0.0 110.837 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -153.27 44.18 0.62 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.5 -174.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.25 -45.22 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.726 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.4 t -90.08 104.34 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.702 0.287 . . . . 0.0 110.462 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.5 m -79.89 90.12 5.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.904 ' SG ' ' HD2' ' A' ' 11' ' ' PRO . 4.5 t -92.17 155.9 42.43 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.125 -172.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.904 ' HD2' ' SG ' ' A' ' 10' ' ' CYS . 7.4 Cg_endo -45.3 -74.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 123.941 3.094 . . . . 0.0 112.873 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.635 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 46.8 t -84.4 150.89 25.03 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.15 52.12 4.32 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.931 -176.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.809 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -81.5 -100.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.816 176.16 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.436 ' H ' HD12 ' A' ' 24' ' ' ILE . 15.3 ptp180 -154.79 160.74 41.49 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.1 p -104.2 104.26 14.15 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.445 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 7.9 p -78.99 59.94 2.79 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.97 -174.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.8 mm -55.01 -18.12 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.278 0.561 . . . . 0.0 111.12 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.8 m -78.59 -39.38 23.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.641 0.734 . . . . 0.0 110.808 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.488 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 16.0 t70 -93.41 -71.21 0.67 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.518 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.488 ' HG2' ' OD2' ' A' ' 20' ' ' ASP . 23.0 pttm -156.75 178.1 10.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.502 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -46.02 -49.21 16.43 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 65.6 m -149.74 154.51 38.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.268 0.556 . . . . 0.0 110.211 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.436 HD12 ' H ' ' A' ' 15' ' ' ARG . 0.8 OUTLIER -90.04 -25.25 5.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.814 -173.122 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.809 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 53.71 37.92 27.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.887 -171.079 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -117.16 171.95 7.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.666 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.003 179.156 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 93.0 mt . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 121.181 0.515 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -127.77 34.09 4.69 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -100.26 152.86 37.95 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.291 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.95 141.67 55.54 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.044 2.496 . . . . 0.0 111.823 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.1 t -65.18 124.67 22.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.151 0.5 . . . . 0.0 111.812 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -155.62 66.86 0.62 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.327 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.5 -83.44 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.388 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -73.48 120.47 22.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.9 m -79.55 109.19 13.69 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.351 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.2 m -79.88 139.69 53.94 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.008 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.438 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 13.3 Cg_endo -55.8 -69.42 0.05 OUTLIER 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.929 2.419 . . . . 0.0 112.425 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.461 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 3.4 m -81.61 165.97 20.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.242 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.17 45.3 2.99 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.93 -174.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.645 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -89.03 -104.44 0.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.557 0.218 . . . . 0.0 111.336 177.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.44 ' HG3' ' CG1' ' A' ' 24' ' ' ILE . 2.0 ptm180 -148.25 156.26 42.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.888 0.375 . . . . 0.0 110.517 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.2 m -89.32 108.45 19.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.768 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.453 ' HB2' HG22 ' A' ' 24' ' ' ILE . 5.8 t -82.63 52.77 2.17 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 30.9 mm -64.99 -16.06 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.378 0.609 . . . . 0.0 110.593 -175.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 m -78.06 -36.99 22.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.526 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 28.4 t70 -90.97 -55.0 3.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.75 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 15.4 pttm -155.32 -123.53 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.768 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.22 -65.84 0.97 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.231 0.539 . . . . 0.0 110.908 176.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 36.5 m -136.9 155.47 49.72 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -175.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.453 HG22 ' HB2' ' A' ' 17' ' ' SER . 0.8 OUTLIER -85.97 -14.53 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -175.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.645 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 52.08 47.45 24.73 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.082 -176.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.438 ' HG2' ' HB ' ' A' ' 24' ' ' ILE . 74.3 mmtt -80.82 62.61 4.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.139 0.495 . . . . 0.0 110.267 175.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.338 -0.839 . . . . 0.0 109.807 -178.942 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.408 HD23 ' H1 ' ' A' ' 1' ' ' LEU . 1.6 pt? . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.888 0.375 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -144.17 159.36 42.77 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.452 ' HB2' ' HB2' ' A' ' 6' ' ' ASN . 10.2 p30 -147.9 151.08 37.57 Favored Pre-proline 0 C--N 1.322 -0.63 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.063 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.56 -53.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.438 2.092 . . . . 0.0 111.159 171.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.4 t -152.23 32.86 0.52 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.552 0.691 . . . . 0.0 110.175 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.452 ' HB2' ' HB2' ' A' ' 3' ' ' ASN . 1.6 m-20 -92.31 24.32 3.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.52 -177.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.59 141.88 8.3 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.9 t -79.77 81.05 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.48 0.657 . . . . 0.0 110.487 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 t -115.11 31.35 6.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 122.232 1.015 . . . . 0.0 109.214 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.3 m -140.76 140.06 21.18 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.533 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.465 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 15.0 Cg_endo -56.54 -25.29 57.97 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 124.186 3.257 . . . . 0.0 112.893 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.7 m -139.45 155.58 47.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.394 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.4 45.16 3.34 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.351 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.708 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -80.02 -96.7 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.436 -0.106 . . . . 0.0 111.221 177.294 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.412 ' O ' HG13 ' A' ' 24' ' ' ILE . 71.9 mtm180 -137.62 130.62 30.37 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.195 0.522 . . . . 0.0 111.06 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.438 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 22.5 m -86.62 84.92 7.3 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.678 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.469 ' CB ' HG23 ' A' ' 24' ' ' ILE . 26.5 p -78.99 44.62 0.57 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.721 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.6 mm -64.32 -18.3 22.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 121.722 0.772 . . . . 0.0 110.329 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 m -78.24 -33.37 17.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.415 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -87.93 -52.91 5.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.421 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -160.94 -127.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.338 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -83.23 -134.81 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.457 ' SG ' ' HE1' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -94.31 154.66 17.39 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.469 HG23 ' CB ' ' A' ' 17' ' ' SER . 1.6 pp -79.65 -9.49 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -168.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.708 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 1.9 mptm? 43.74 60.74 2.55 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 24' ' ' ILE . 47.0 mmtm -125.53 51.99 1.67 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.92 0.391 . . . . 0.0 111.057 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.545 176.672 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 98.6 mt . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.827 0.346 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -95.02 47.04 1.13 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.182 0.515 . . . . 0.0 110.512 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -67.88 153.88 94.5 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.054 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.46 72.4 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.193 2.595 . . . . 0.0 113.304 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 16' ' ' CYS . 3.6 t -81.15 -45.45 16.37 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 54.34 56.44 6.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.529 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.94 121.23 1.01 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.418 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.9 m -91.19 -22.0 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.186 0.517 . . . . 0.0 110.59 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 m -88.18 75.61 8.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.885 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 68.9 m -151.34 111.22 3.01 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.618 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.539 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 18.6 Cg_endo -58.49 -31.51 94.43 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.189 2.593 . . . . 0.0 112.57 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.477 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 24.0 m -126.18 160.38 30.38 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.64 48.62 3.08 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.549 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.539 ' OH ' ' HG2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -84.38 -97.74 0.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.469 0.174 . . . . 0.0 111.469 177.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 24' ' ' ILE . 77.7 mtm180 -136.0 133.47 37.53 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.497 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 57.0 m -86.2 93.21 8.99 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.651 -171.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.522 ' HB2' HG22 ' A' ' 24' ' ' ILE . 7.8 t -79.94 47.82 0.91 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.304 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 42.2 mm -66.08 -17.44 22.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.76 0.79 . . . . 0.0 109.832 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.4 m -77.95 -35.34 20.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.894 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -91.47 -49.57 6.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.16 0.505 . . . . 0.0 110.676 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.52 ' HE3' ' O ' ' A' ' 23' ' ' CYS . 47.5 pttt -157.02 -121.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.804 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.418 ' HG3' ' H ' ' A' ' 23' ' ' CYS . 5.9 pt20 -91.66 -70.98 0.66 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.459 -0.151 . . . . 0.0 111.177 173.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.52 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -148.2 166.05 29.1 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.025 -0.422 . . . . 0.0 110.406 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.522 HG22 ' HB2' ' A' ' 17' ' ' SER . 1.4 pp -91.15 -3.58 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -167.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.539 ' HB3' ' HZ1' ' A' ' 25' ' ' LYS . 3.6 mmmp? 51.93 31.77 9.0 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 177.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.423 ' HB2' HD13 ' A' ' 24' ' ' ILE . 48.1 mmtm -111.9 85.73 2.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.118 0.485 . . . . 0.0 110.056 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 . . . . . 0 C--O 1.25 1.09 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.263 -176.779 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 121.251 0.548 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -101.97 22.16 13.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.355 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.515 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 26.0 t-20 -57.41 -53.26 67.31 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' A' ' 3' ' ' ASN . 9.6 Cg_endo -91.44 49.06 0.66 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.615 2.21 . . . . 0.0 112.415 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.0 t -172.45 131.59 0.59 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.066 0.46 . . . . 0.0 110.9 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -122.29 2.08 9.7 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.883 0.849 . . . . 0.0 109.714 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.86 98.41 0.18 Allowed Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.018 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.8 t -76.37 77.42 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.429 0.633 . . . . 0.0 111.293 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.7 t -99.33 25.05 7.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.331 1.063 . . . . 0.0 108.992 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 18.6 m -107.07 140.83 21.8 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.795 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.94 -27.2 84.38 Favored 'Trans proline' 0 N--CA 1.474 0.328 0 C-N-CA 124.08 3.187 . . . . 0.0 112.912 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.0 t -134.47 158.27 44.35 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.55 46.98 3.54 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.083 -173.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.536 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -82.43 -102.71 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.975 174.705 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.435 ' HG3' HG12 ' A' ' 24' ' ' ILE . 15.9 ptm180 -143.63 159.14 42.99 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.3 m -106.92 93.35 4.51 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.434 ' CB ' HG21 ' A' ' 24' ' ' ILE . 4.8 p -79.9 42.8 0.56 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.13 -175.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.2 mm -55.13 -19.16 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.427 0.632 . . . . 0.0 110.909 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.5 m -77.5 -38.18 25.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.767 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.501 ' OD2' ' HD2' ' A' ' 21' ' ' LYS . 37.3 t70 -92.59 -71.02 0.67 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.207 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.501 ' HD2' ' OD2' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -149.3 157.42 43.32 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 172.176 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -38.72 -53.68 1.63 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -165.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.6 m -139.6 146.89 40.36 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.936 -0.477 . . . . 0.0 110.893 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.453 HD12 ' HB2' ' A' ' 14' ' ' TYR . 1.4 pp -84.69 -9.99 11.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -174.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.536 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 9.7 mptt 61.47 20.34 11.09 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.432 ' HB2' HD13 ' A' ' 24' ' ' ILE . 14.5 mmmm -98.28 81.6 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.76 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 C--O 1.25 1.112 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.405 178.961 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.503 ' H3 ' HD12 ' A' ' 1' ' ' LEU . 8.0 mp . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.711 0.291 . . . . 0.0 110.408 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 3' ' ' ASN . 2.4 m-20 -89.51 133.67 34.47 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.49 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 52.1 m-80 67.54 170.47 0.1 Allowed Pre-proline 0 C--O 1.235 0.333 0 O-C-N 123.661 0.601 . . . . 0.0 111.222 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 3' ' ' ASN . 6.1 Cg_endo -50.46 -38.72 54.21 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.468 2.112 . . . . 0.0 111.856 171.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.0 t -123.66 133.94 53.83 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.818 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -111.88 62.25 0.62 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.593 0.711 . . . . 0.0 109.772 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.61 64.73 2.81 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.894 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.6 p -69.83 -16.8 20.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.347 0.594 . . . . 0.0 110.946 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.4 t -122.67 31.03 6.22 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.332 1.063 . . . . 0.0 109.205 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 37.0 m -135.77 142.4 40.54 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.509 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.45 -3.68 6.86 Favored 'Trans proline' 0 N--CA 1.475 0.431 0 C-N-CA 123.527 2.818 . . . . 0.0 113.514 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 t 56.04 32.52 20.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.864 0.84 . . . . 0.0 111.364 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.25 -46.79 3.72 Favored Glycine 0 C--N 1.316 -0.555 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.025 176.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.707 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -91.34 -101.16 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.663 -0.268 . . . . 0.0 111.088 176.223 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.426 ' H ' ' HD1' ' A' ' 14' ' ' TYR . 12.0 ptm180 -161.4 175.43 12.22 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.562 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 3.7 p -109.78 103.24 12.02 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.168 0.508 . . . . 0.0 110.178 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.8 p -79.16 59.87 2.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.044 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 38.7 mm -62.8 -15.94 16.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.789 0.804 . . . . 0.0 110.113 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.7 m -77.5 -34.92 21.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.549 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -91.98 -55.81 3.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.154 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 11.6 pttp -154.79 -126.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.22 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.414 ' HG3' ' H ' ' A' ' 23' ' ' CYS . 3.0 pt20 -91.37 -58.56 2.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 118.422 0.556 . . . . 0.0 111.004 174.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.562 ' SG ' ' HA ' ' A' ' 16' ' ' CYS . 9.4 m -148.67 159.86 43.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.054 0.454 . . . . 0.0 110.378 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.511 ' HB ' ' HG2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -90.89 -11.29 9.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -168.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.707 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 31.3 mmmt 55.28 34.72 23.38 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.511 ' HG2' ' HB ' ' A' ' 24' ' ' ILE . 74.9 mmtt -81.04 71.31 8.01 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.24 0.543 . . . . 0.0 110.361 176.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.848 -177.386 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.653 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 10.3 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.945 0.403 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -83.24 13.41 4.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.793 -174.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.66 -77.01 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.996 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.653 ' O ' ' HB2' ' A' ' 5' ' ' CYS . 8.4 p -77.14 159.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.4 m -102.25 117.5 34.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.723 0.296 . . . . 0.0 110.685 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.1 m -79.24 127.28 79.55 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.12 0.486 . . . . 0.0 110.528 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.577 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 19.4 Cg_endo -58.28 -26.58 77.49 Favored 'Trans proline' 0 N--CA 1.474 0.351 0 C-N-CA 124.077 3.185 . . . . 0.0 113.554 -177.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.563 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 23.2 t -131.73 165.12 24.45 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.38 50.54 4.08 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.712 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.748 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -94.94 -118.58 0.1 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 122.735 -0.274 . . . . 0.0 111.447 175.107 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -134.23 159.14 41.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.09 0.471 . . . . 0.0 110.78 -176.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.3 m -101.08 95.89 6.87 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.582 -173.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.522 ' HB3' HG23 ' A' ' 24' ' ' ILE . 7.9 p -78.95 51.94 1.19 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.54 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 45.3 mm -62.14 -18.7 20.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.242 0.544 . . . . 0.0 111.279 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.22 -36.97 21.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.438 0.637 . . . . 0.0 110.684 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 29.7 t70 -91.09 -48.94 6.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.105 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 15.6 pttm -159.53 -138.81 0.06 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.197 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -92.09 -77.5 0.43 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.172 0.51 . . . . 0.0 110.163 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 77.0 m -121.92 143.24 49.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.377 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.522 HG23 ' HB3' ' A' ' 17' ' ' SER . 1.3 pp -80.05 -15.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -175.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.748 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 13.8 mptt 55.84 29.29 13.77 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.505 ' C ' ' HD3' ' A' ' 26' ' ' LYS . 8.6 tmtm? -91.31 106.11 18.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.218 0.532 . . . . 0.0 109.809 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.44 178.645 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -98.61 136.65 38.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.182 0.515 . . . . 0.0 110.711 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.75 -146.81 4.73 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.647 HG13 ' H ' ' A' ' 9' ' ' THR . 5.9 p -74.27 -63.27 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 117.028 0.414 . . . . 0.0 110.47 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.647 ' H ' HG13 ' A' ' 8' ' ' VAL . 57.2 m -156.18 81.01 0.99 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.068 0.461 . . . . 0.0 110.53 177.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.1 m -124.96 127.65 25.04 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.54 167.24 25.93 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.022 1.815 . . . . 0.0 110.992 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.9 m -94.91 38.08 1.13 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.715 0.769 . . . . 0.0 110.644 -173.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.55 -51.66 2.47 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.451 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.646 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -105.55 -104.54 0.32 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.482 0.179 . . . . 0.0 111.482 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.511 ' H ' HD11 ' A' ' 24' ' ' ILE . 18.2 ptp180 -152.6 169.43 22.68 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.439 ' HB2' HG12 ' A' ' 18' ' ' ILE . 31.8 p -98.19 126.89 43.85 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 t -102.6 40.35 1.38 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.712 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.439 HG12 ' HB2' ' A' ' 16' ' ' CYS . 34.7 mm -62.03 -21.3 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.5 -171.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.0 m -77.7 -37.01 23.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.238 0.542 . . . . 0.0 110.905 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.485 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 11.9 t70 -91.97 -47.03 7.51 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.677 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HG2' ' OD2' ' A' ' 20' ' ' ASP . 15.5 pttm -160.36 -146.52 0.14 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.753 -176.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.455 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 29.1 tt0 -68.89 -85.7 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.338 0.589 . . . . 0.0 111.011 172.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.455 ' SG ' ' HG2' ' A' ' 22' ' ' GLN . 3.2 m -132.64 171.17 14.19 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.511 HD11 ' H ' ' A' ' 15' ' ' ARG . 1.0 OUTLIER -96.7 -13.48 8.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -176.616 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.646 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 14.5 mptt 55.09 30.93 15.24 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 123.38 0.425 . . . . 0.0 111.651 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -79.31 81.0 5.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.309 -177.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.504 179.437 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 121.375 0.607 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 62.41 27.47 16.35 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.798 171.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.96 -64.7 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.0 t -90.54 135.77 25.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 175.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 m -89.43 105.07 17.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.101 0.476 . . . . 0.0 110.703 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.4 m -80.96 138.94 49.57 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.075 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.481 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 18.0 Cg_endo -58.09 -23.64 62.05 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 124.064 3.176 . . . . 0.0 112.931 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.403 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 41.7 m -136.71 159.86 40.56 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.15 49.01 3.91 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.555 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.768 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -90.45 -105.98 0.09 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.588 0.232 . . . . 0.0 111.516 175.64 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -132.66 148.47 52.35 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 77.0 m -91.94 111.57 23.16 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.508 ' HB2' HG23 ' A' ' 24' ' ' ILE . 11.5 t -87.05 50.34 2.0 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.121 -174.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.6 mm -65.34 -17.09 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.963 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.3 m -78.39 -38.04 22.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.704 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.454 ' HB2' ' OG ' ' A' ' 17' ' ' SER . 12.9 m-20 -90.98 -67.19 0.87 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.681 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.522 ' HB2' ' H ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -143.2 -124.83 0.09 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.473 -177.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.522 ' H ' ' HB2' ' A' ' 21' ' ' LYS . 20.5 pt20 -93.23 -57.73 2.52 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.975 0.807 . . . . 0.0 111.904 174.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.418 ' N ' ' HG3' ' A' ' 22' ' ' GLN . 60.8 m -139.26 154.44 47.97 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -174.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 17' ' ' SER . 1.0 OUTLIER -87.84 -18.32 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -173.335 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.768 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 46.7 54.75 8.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.895 0.379 . . . . 0.0 110.873 -174.179 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -152.95 128.43 9.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.09 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.55 178.257 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.456 -0.156 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -80.1 57.55 2.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.783 0.801 . . . . 0.0 109.775 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.61 -71.94 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.7 t -91.58 118.53 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.3 m -82.34 130.94 35.21 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.965 0.412 . . . . 0.0 110.794 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.3 m -84.79 153.96 61.11 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.795 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.535 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 6.9 Cg_endo -48.84 -71.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.261 2.641 . . . . 0.0 112.494 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.518 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 33.0 m -86.92 163.28 17.23 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.72 51.68 3.27 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.54 -175.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.786 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -88.32 -100.97 0.08 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 121.343 -0.143 . . . . 0.0 111.349 176.42 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -148.42 153.79 39.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.129 0.49 . . . . 0.0 110.659 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.3 m -93.91 95.61 9.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.161 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.511 ' CB ' HG23 ' A' ' 24' ' ' ILE . 5.6 p -82.11 45.23 0.91 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.115 -177.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.2 mm -56.68 -16.28 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.365 0.602 . . . . 0.0 111.727 -173.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.1 m -77.58 -36.99 23.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.419 0.628 . . . . 0.0 110.139 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -91.04 -74.74 0.49 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.303 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -148.97 160.37 43.35 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.446 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -39.36 -57.98 1.3 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -168.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.412 ' SG ' ' HD2' ' A' ' 11' ' ' PRO . 33.7 m -136.38 140.56 43.32 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.529 HD11 ' HB2' ' A' ' 14' ' ' TYR . 1.3 pp -78.86 -16.59 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -175.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.786 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 52.98 35.03 18.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.944 -176.641 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.451 ' H ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -88.36 101.32 13.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.289 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.891 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 121.95 0.881 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -153.27 44.18 0.62 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.5 -174.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.25 -45.22 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.726 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.4 t -90.08 104.34 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.702 0.287 . . . . 0.0 110.462 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.5 m -79.89 90.12 5.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.897 ' SG ' ' HD2' ' A' ' 11' ' ' PRO . 4.5 t -92.17 155.9 42.43 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.125 -172.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.897 ' HD2' ' SG ' ' A' ' 10' ' ' CYS . 7.4 Cg_endo -45.3 -74.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 123.941 3.094 . . . . 0.0 112.873 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.645 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 46.8 t -84.4 150.89 25.03 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.15 52.12 4.32 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.931 -176.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.817 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -81.5 -100.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.816 176.16 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.493 ' H ' HD11 ' A' ' 24' ' ' ILE . 15.3 ptp180 -154.79 160.74 41.49 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.1 p -104.2 104.26 14.15 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.464 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 7.9 p -78.99 59.94 2.79 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.97 -174.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.8 mm -55.01 -18.12 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.278 0.561 . . . . 0.0 111.12 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.8 m -78.59 -39.38 23.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.641 0.734 . . . . 0.0 110.808 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.496 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 16.0 t70 -93.41 -71.21 0.67 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.518 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.496 ' HG2' ' OD2' ' A' ' 20' ' ' ASP . 23.0 pttm -156.75 178.1 10.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.502 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -46.02 -49.21 16.43 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 65.6 m -149.74 154.51 38.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.268 0.556 . . . . 0.0 110.211 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.493 HD11 ' H ' ' A' ' 15' ' ' ARG . 0.8 OUTLIER -90.04 -25.25 5.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.814 -173.122 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.817 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 53.71 37.92 27.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.887 -171.079 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.409 ' H ' HD13 ' A' ' 24' ' ' ILE . 75.7 mmtt -117.16 171.95 7.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.666 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.003 179.156 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.1 t . . . . . 0 C--O 1.236 0.356 0 CA-C-O 121.151 0.5 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -155.62 66.86 0.62 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.327 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.5 -83.44 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.388 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -73.48 120.47 22.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.9 m -79.55 109.19 13.69 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.351 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.2 m -79.88 139.69 53.94 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.008 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 13.3 Cg_endo -55.8 -69.42 0.05 OUTLIER 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.929 2.419 . . . . 0.0 112.425 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.459 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 3.4 m -81.61 165.97 20.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.242 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.17 45.3 2.99 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.93 -174.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.66 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -89.03 -104.44 0.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.557 0.218 . . . . 0.0 111.336 177.871 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.486 ' H ' HD11 ' A' ' 24' ' ' ILE . 2.0 ptm180 -148.25 156.26 42.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.888 0.375 . . . . 0.0 110.517 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.2 m -89.32 108.45 19.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.768 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.484 ' HB2' HG23 ' A' ' 24' ' ' ILE . 5.8 t -82.63 52.77 2.17 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 30.9 mm -64.99 -16.06 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.378 0.609 . . . . 0.0 110.593 -175.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 m -78.06 -36.99 22.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.526 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 28.4 t70 -90.97 -55.0 3.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.75 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 15.4 pttm -155.32 -123.53 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.768 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.22 -65.84 0.97 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.231 0.539 . . . . 0.0 110.908 176.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.406 ' HA ' ' H ' ' A' ' 17' ' ' SER . 36.5 m -136.9 155.47 49.72 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -175.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.486 HD11 ' H ' ' A' ' 15' ' ' ARG . 0.8 OUTLIER -85.97 -14.53 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -175.364 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.66 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 52.08 47.45 24.73 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.082 -176.353 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HG2' ' HB ' ' A' ' 24' ' ' ILE . 74.3 mmtt -80.82 62.61 4.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.139 0.495 . . . . 0.0 110.267 175.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.338 -0.839 . . . . 0.0 109.807 -178.942 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.233 0.203 0 CA-C-O 121.552 0.691 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -92.31 24.32 3.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.52 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.59 141.88 8.3 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.9 t -79.77 81.05 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.48 0.657 . . . . 0.0 110.487 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 t -115.11 31.35 6.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 122.232 1.015 . . . . 0.0 109.214 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.3 m -140.76 140.06 21.18 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.533 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.478 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 15.0 Cg_endo -56.54 -25.29 57.97 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 124.186 3.257 . . . . 0.0 112.893 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.7 m -139.45 155.58 47.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.394 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.4 45.16 3.34 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.351 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.728 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -80.02 -96.7 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.436 -0.106 . . . . 0.0 111.221 177.294 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.418 ' H ' HD11 ' A' ' 24' ' ' ILE . 71.9 mtm180 -137.62 130.62 30.37 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.195 0.522 . . . . 0.0 111.06 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.441 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 22.5 m -86.62 84.92 7.3 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.678 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.491 ' CB ' HG23 ' A' ' 24' ' ' ILE . 26.5 p -78.99 44.62 0.57 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.721 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.6 mm -64.32 -18.3 22.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 121.722 0.772 . . . . 0.0 110.329 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 m -78.24 -33.37 17.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.415 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -87.93 -52.91 5.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.421 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -160.94 -127.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.338 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -83.23 -134.81 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.455 ' SG ' ' HE1' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -94.31 154.66 17.39 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.491 HG23 ' CB ' ' A' ' 17' ' ' SER . 1.6 pp -79.65 -9.49 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -168.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.728 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 1.9 mptm? 43.74 60.74 2.55 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 24' ' ' ILE . 47.0 mmtm -125.53 51.99 1.67 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.92 0.391 . . . . 0.0 111.057 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.545 176.672 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 16' ' ' CYS . 3.6 t . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 54.34 56.44 6.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.529 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.94 121.23 1.01 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.418 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.9 m -91.19 -22.0 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.186 0.517 . . . . 0.0 110.59 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 m -88.18 75.61 8.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.885 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.437 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 68.9 m -151.34 111.22 3.01 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.618 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.547 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 18.6 Cg_endo -58.49 -31.51 94.43 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.189 2.593 . . . . 0.0 112.57 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.484 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 24.0 m -126.18 160.38 30.38 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.64 48.62 3.08 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.549 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.579 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -84.38 -97.74 0.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.469 0.174 . . . . 0.0 111.469 177.357 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.444 ' O ' HG13 ' A' ' 24' ' ' ILE . 77.7 mtm180 -136.0 133.47 37.53 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.5 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 57.0 m -86.2 93.21 8.99 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.651 -171.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.71 ' HB2' HG23 ' A' ' 24' ' ' ILE . 7.8 t -79.94 47.82 0.91 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.304 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 42.2 mm -66.08 -17.44 22.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.76 0.79 . . . . 0.0 109.832 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 19' ' ' VAL . 4.4 m -77.95 -35.34 20.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.894 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -91.47 -49.57 6.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.16 0.505 . . . . 0.0 110.676 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.529 ' HE3' ' O ' ' A' ' 23' ' ' CYS . 47.5 pttt -157.02 -121.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.804 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.423 ' HG3' ' H ' ' A' ' 23' ' ' CYS . 5.9 pt20 -91.66 -70.98 0.66 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.459 -0.151 . . . . 0.0 111.177 173.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.529 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -148.2 166.05 29.1 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.025 -0.422 . . . . 0.0 110.406 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.71 HG23 ' HB2' ' A' ' 17' ' ' SER . 1.4 pp -91.15 -3.58 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -167.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 3.6 mmmp? 51.93 31.77 9.0 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 177.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.433 ' HB2' HD13 ' A' ' 24' ' ' ILE . 48.1 mmtm -111.9 85.73 2.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.118 0.485 . . . . 0.0 110.056 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 . . . . . 0 C--O 1.25 1.09 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.263 -176.779 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.0 t . . . . . 0 N--CA 1.458 -0.047 0 CA-C-O 121.066 0.46 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -122.29 2.08 9.7 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.883 0.849 . . . . 0.0 109.714 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.86 98.41 0.18 Allowed Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.018 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.8 t -76.37 77.42 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.429 0.633 . . . . 0.0 111.293 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.7 t -99.33 25.05 7.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.331 1.063 . . . . 0.0 108.992 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 18.6 m -107.07 140.83 21.8 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.795 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.94 -27.2 84.38 Favored 'Trans proline' 0 N--CA 1.474 0.328 0 C-N-CA 124.08 3.187 . . . . 0.0 112.912 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.0 t -134.47 158.27 44.35 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.55 46.98 3.54 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.083 -173.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.571 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -82.43 -102.71 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.975 174.705 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.483 ' HG3' HG12 ' A' ' 24' ' ' ILE . 15.9 ptm180 -143.63 159.14 42.99 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.3 m -106.92 93.35 4.51 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.46 ' CB ' HG23 ' A' ' 24' ' ' ILE . 4.8 p -79.9 42.8 0.56 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.13 -175.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.2 mm -55.13 -19.16 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.427 0.632 . . . . 0.0 110.909 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.5 m -77.5 -38.18 25.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.767 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.52 ' OD2' ' HD2' ' A' ' 21' ' ' LYS . 37.3 t70 -92.59 -71.02 0.67 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.207 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.52 ' HD2' ' OD2' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -149.3 157.42 43.32 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 172.176 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -38.72 -53.68 1.63 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -165.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.6 m -139.6 146.89 40.36 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.936 -0.477 . . . . 0.0 110.893 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.483 HG12 ' HG3' ' A' ' 15' ' ' ARG . 1.4 pp -84.69 -9.99 11.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -174.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 9.7 mptt 61.47 20.34 11.09 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.441 ' HB2' HD13 ' A' ' 24' ' ' ILE . 14.5 mmmm -98.28 81.6 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.76 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 C--O 1.25 1.112 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.405 178.961 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -111.88 62.25 0.62 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.593 0.711 . . . . 0.0 109.772 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.61 64.73 2.81 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.894 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.6 p -69.83 -16.8 20.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.347 0.594 . . . . 0.0 110.946 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.4 t -122.67 31.03 6.22 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.332 1.063 . . . . 0.0 109.205 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 37.0 m -135.77 142.4 40.54 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.509 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.45 -3.68 6.86 Favored 'Trans proline' 0 N--CA 1.475 0.431 0 C-N-CA 123.527 2.818 . . . . 0.0 113.514 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 t 56.04 32.52 20.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.864 0.84 . . . . 0.0 111.364 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.25 -46.79 3.72 Favored Glycine 0 C--N 1.316 -0.555 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.025 176.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.733 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -91.34 -101.16 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.663 -0.268 . . . . 0.0 111.088 176.223 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.415 ' H ' ' HD1' ' A' ' 14' ' ' TYR . 12.0 ptm180 -161.4 175.43 12.22 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.573 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 3.7 p -109.78 103.24 12.02 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.168 0.508 . . . . 0.0 110.178 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.8 p -79.16 59.87 2.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.044 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 38.7 mm -62.8 -15.94 16.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.789 0.804 . . . . 0.0 110.113 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.7 m -77.5 -34.92 21.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.549 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -91.98 -55.81 3.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.154 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 11.6 pttp -154.79 -126.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.22 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.421 ' HG3' ' H ' ' A' ' 23' ' ' CYS . 8.8 pt20 -91.37 -58.56 2.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 118.422 0.556 . . . . 0.0 111.004 174.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.573 ' SG ' ' HA ' ' A' ' 16' ' ' CYS . 9.4 m -148.67 159.86 43.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.054 0.454 . . . . 0.0 110.378 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.55 ' HB ' ' HG2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -90.89 -11.29 9.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -168.542 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.733 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 31.3 mmmt 55.28 34.72 23.38 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.55 ' HG2' ' HB ' ' A' ' 24' ' ' ILE . 74.9 mmtt -81.04 71.31 8.01 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.24 0.543 . . . . 0.0 110.361 176.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.848 -177.386 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 66.0 tp . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.408 0.147 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -103.15 27.27 7.34 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.559 -174.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.432 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 62.2 t30 -66.78 -50.74 42.96 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 175.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 3' ' ' ASN . 43.3 Cg_endo -69.45 140.98 45.23 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.783 1.655 . . . . 0.0 110.742 168.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.653 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 10.3 m -59.76 137.95 57.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.057 -174.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -83.24 13.41 4.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.793 -174.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.66 -77.01 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.996 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.653 ' O ' ' HB2' ' A' ' 5' ' ' CYS . 8.4 p -77.14 159.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.4 m -102.25 117.5 34.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.723 0.296 . . . . 0.0 110.685 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.1 m -79.24 127.28 79.55 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.12 0.486 . . . . 0.0 110.528 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.577 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 19.4 Cg_endo -58.28 -26.58 77.49 Favored 'Trans proline' 0 N--CA 1.474 0.351 0 C-N-CA 124.077 3.185 . . . . 0.0 113.554 -177.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.563 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 23.2 t -131.73 165.12 24.45 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.38 50.54 4.08 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.712 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.748 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -94.94 -118.58 0.1 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 122.735 -0.274 . . . . 0.0 111.447 175.107 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -134.23 159.14 41.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.09 0.471 . . . . 0.0 110.78 -176.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.3 m -101.08 95.89 6.87 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.582 -173.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.522 ' HB3' HG23 ' A' ' 24' ' ' ILE . 7.9 p -78.95 51.94 1.19 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.54 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 45.3 mm -62.14 -18.7 20.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.242 0.544 . . . . 0.0 111.279 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.22 -36.97 21.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.438 0.637 . . . . 0.0 110.684 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 29.7 t70 -91.09 -48.94 6.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.105 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 15.6 pttm -159.53 -138.81 0.06 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.197 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -92.09 -77.5 0.43 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.172 0.51 . . . . 0.0 110.163 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 77.0 m -121.92 143.24 49.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.377 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.522 HG23 ' HB3' ' A' ' 17' ' ' SER . 1.3 pp -80.05 -15.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -175.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.748 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 13.8 mptt 55.84 29.29 13.77 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.505 ' C ' ' HD3' ' A' ' 26' ' ' LYS . 8.6 tmtm? -91.31 106.11 18.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.218 0.532 . . . . 0.0 109.809 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.44 178.645 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 12' ' ' SER . 6.8 t30 58.4 63.13 1.79 Allowed 'General case' 0 N--CA 1.463 0.201 0 O-C-N 123.621 0.576 . . . . 0.0 110.608 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -103.87 106.14 51.43 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.171 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -74.48 68.26 5.32 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.99 2.46 . . . . 0.0 111.651 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.3 t -93.89 145.93 24.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.201 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -98.61 136.65 38.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.182 0.515 . . . . 0.0 110.711 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.75 -146.81 4.73 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.647 HG13 ' H ' ' A' ' 9' ' ' THR . 5.9 p -74.27 -63.27 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 117.028 0.414 . . . . 0.0 110.47 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.647 ' H ' HG13 ' A' ' 8' ' ' VAL . 57.2 m -156.18 81.01 0.99 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.068 0.461 . . . . 0.0 110.53 177.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.1 m -124.96 127.65 25.04 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.54 167.24 25.93 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.022 1.815 . . . . 0.0 110.992 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 20.9 m -94.91 38.08 1.13 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.715 0.769 . . . . 0.0 110.644 -173.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.55 -51.66 2.47 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.451 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.646 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -105.55 -104.54 0.32 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.482 0.179 . . . . 0.0 111.482 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.511 ' H ' HD11 ' A' ' 24' ' ' ILE . 18.2 ptp180 -152.6 169.43 22.68 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.439 ' HB2' HG12 ' A' ' 18' ' ' ILE . 31.8 p -98.19 126.89 43.85 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 t -102.6 40.35 1.38 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.712 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.439 HG12 ' HB2' ' A' ' 16' ' ' CYS . 34.7 mm -62.03 -21.3 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.5 -171.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.0 m -77.7 -37.01 23.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.238 0.542 . . . . 0.0 110.905 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.485 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 11.9 t70 -91.97 -47.03 7.51 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.677 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HG2' ' OD2' ' A' ' 20' ' ' ASP . 15.5 pttm -160.36 -146.52 0.14 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.753 -176.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.455 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 29.1 tt0 -68.89 -85.7 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.338 0.589 . . . . 0.0 111.011 172.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.455 ' SG ' ' HG2' ' A' ' 22' ' ' GLN . 3.2 m -132.64 171.17 14.19 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.511 HD11 ' H ' ' A' ' 15' ' ' ARG . 1.0 OUTLIER -96.7 -13.48 8.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -176.616 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.646 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 14.5 mptt 55.09 30.93 15.24 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 123.38 0.425 . . . . 0.0 111.651 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -79.31 81.0 5.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.309 -177.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.504 179.437 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -128.14 86.14 2.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.264 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -128.1 78.01 75.95 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.957 0.408 . . . . 0.0 110.703 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.68 93.55 1.02 Allowed 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.543 2.162 . . . . 0.0 112.037 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.4 p -74.82 -25.11 58.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.375 0.607 . . . . 0.0 110.325 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 62.41 27.47 16.35 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.798 171.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.96 -64.7 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.0 t -90.54 135.77 25.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 175.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 m -89.43 105.07 17.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.101 0.476 . . . . 0.0 110.703 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.4 m -80.96 138.94 49.57 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.075 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.481 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 18.0 Cg_endo -58.09 -23.64 62.05 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 124.064 3.176 . . . . 0.0 112.931 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.403 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 41.7 m -136.71 159.86 40.56 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.15 49.01 3.91 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.555 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.768 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -90.45 -105.98 0.09 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.588 0.232 . . . . 0.0 111.516 175.64 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -132.66 148.47 52.35 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 77.0 m -91.94 111.57 23.16 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.508 ' HB2' HG23 ' A' ' 24' ' ' ILE . 11.5 t -87.05 50.34 2.0 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.121 -174.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.6 mm -65.34 -17.09 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.963 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.3 m -78.39 -38.04 22.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.704 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.454 ' HB2' ' OG ' ' A' ' 17' ' ' SER . 12.9 m-20 -90.98 -67.19 0.87 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.681 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.522 ' HB2' ' H ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -143.2 -124.83 0.09 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.473 -177.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.522 ' H ' ' HB2' ' A' ' 21' ' ' LYS . 20.5 pt20 -93.23 -57.73 2.52 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.975 0.807 . . . . 0.0 111.904 174.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.418 ' N ' ' HG3' ' A' ' 22' ' ' GLN . 60.8 m -139.26 154.44 47.97 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -174.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 17' ' ' SER . 1.0 OUTLIER -87.84 -18.32 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -173.335 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.768 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 46.7 54.75 8.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.895 0.379 . . . . 0.0 110.873 -174.179 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -152.95 128.43 9.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.09 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.55 178.257 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 120.707 0.289 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -66.25 137.59 57.06 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.165 0.507 . . . . 0.0 111.091 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -130.86 150.31 76.17 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.887 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.41 172.86 14.63 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.5 2.133 . . . . 0.0 111.439 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 30.1 t -66.7 -29.8 69.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -80.1 57.55 2.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.783 0.801 . . . . 0.0 109.775 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.61 -71.94 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.7 t -91.58 118.53 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.3 m -82.34 130.94 35.21 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.965 0.412 . . . . 0.0 110.794 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.3 m -84.79 153.96 61.11 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.795 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.535 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 6.9 Cg_endo -48.84 -71.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.261 2.641 . . . . 0.0 112.494 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.518 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 33.0 m -86.92 163.28 17.23 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.72 51.68 3.27 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.54 -175.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.786 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -88.32 -100.97 0.08 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 121.343 -0.143 . . . . 0.0 111.349 176.42 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -148.42 153.79 39.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.129 0.49 . . . . 0.0 110.659 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.3 m -93.91 95.61 9.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.161 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.511 ' CB ' HG23 ' A' ' 24' ' ' ILE . 5.6 p -82.11 45.23 0.91 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.115 -177.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.2 mm -56.68 -16.28 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.365 0.602 . . . . 0.0 111.727 -173.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.1 m -77.58 -36.99 23.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.419 0.628 . . . . 0.0 110.139 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -91.04 -74.74 0.49 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.303 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -148.97 160.37 43.35 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.446 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -39.36 -57.98 1.3 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -168.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.412 ' SG ' ' HD2' ' A' ' 11' ' ' PRO . 33.7 m -136.38 140.56 43.32 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.529 HD11 ' HB2' ' A' ' 14' ' ' TYR . 1.3 pp -78.86 -16.59 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -175.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.786 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 52.98 35.03 18.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.944 -176.641 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.451 ' H ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -88.36 101.32 13.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.289 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.891 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.397 0.141 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 58.2 t30 57.61 65.25 1.37 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.694 0.759 . . . . 0.0 109.653 -176.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -126.9 100.55 27.5 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.422 -176.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.38 0.95 9.26 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.979 2.453 . . . . 0.0 111.128 174.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.7 t 71.04 118.57 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.245 -1.343 . . . . 0.0 110.837 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -153.27 44.18 0.62 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.5 -174.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.25 -45.22 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.726 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.4 t -90.08 104.34 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.702 0.287 . . . . 0.0 110.462 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.5 m -79.89 90.12 5.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.897 ' SG ' ' HD2' ' A' ' 11' ' ' PRO . 4.5 t -92.17 155.9 42.43 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.125 -172.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.897 ' HD2' ' SG ' ' A' ' 10' ' ' CYS . 7.4 Cg_endo -45.3 -74.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 123.941 3.094 . . . . 0.0 112.873 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.645 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 46.8 t -84.4 150.89 25.03 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.15 52.12 4.32 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.931 -176.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.817 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -81.5 -100.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.816 176.16 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.493 ' H ' HD11 ' A' ' 24' ' ' ILE . 15.3 ptp180 -154.79 160.74 41.49 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.1 p -104.2 104.26 14.15 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.464 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 7.9 p -78.99 59.94 2.79 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.97 -174.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.8 mm -55.01 -18.12 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.278 0.561 . . . . 0.0 111.12 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.8 m -78.59 -39.38 23.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.641 0.734 . . . . 0.0 110.808 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.496 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 16.0 t70 -93.41 -71.21 0.67 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.518 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.496 ' HG2' ' OD2' ' A' ' 20' ' ' ASP . 23.0 pttm -156.75 178.1 10.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.502 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -46.02 -49.21 16.43 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 65.6 m -149.74 154.51 38.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.268 0.556 . . . . 0.0 110.211 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.493 HD11 ' H ' ' A' ' 15' ' ' ARG . 0.8 OUTLIER -90.04 -25.25 5.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.814 -173.122 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.817 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 53.71 37.92 27.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.887 -171.079 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.409 ' H ' HD13 ' A' ' 24' ' ' ILE . 75.7 mmtt -117.16 171.95 7.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.666 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.003 179.156 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 93.0 mt . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 121.181 0.515 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -127.77 34.09 4.69 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -100.26 152.86 37.95 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.291 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.95 141.67 55.54 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.044 2.496 . . . . 0.0 111.823 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.1 t -65.18 124.67 22.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.151 0.5 . . . . 0.0 111.812 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -155.62 66.86 0.62 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.327 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.5 -83.44 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.388 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -73.48 120.47 22.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.9 m -79.55 109.19 13.69 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.351 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.2 m -79.88 139.69 53.94 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.008 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 13.3 Cg_endo -55.8 -69.42 0.05 OUTLIER 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.929 2.419 . . . . 0.0 112.425 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.459 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 3.4 m -81.61 165.97 20.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.242 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.17 45.3 2.99 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.93 -174.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.66 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -89.03 -104.44 0.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.557 0.218 . . . . 0.0 111.336 177.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.486 ' H ' HD11 ' A' ' 24' ' ' ILE . 2.0 ptm180 -148.25 156.26 42.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.888 0.375 . . . . 0.0 110.517 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.2 m -89.32 108.45 19.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.768 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.484 ' HB2' HG23 ' A' ' 24' ' ' ILE . 5.8 t -82.63 52.77 2.17 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 30.9 mm -64.99 -16.06 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.378 0.609 . . . . 0.0 110.593 -175.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 m -78.06 -36.99 22.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.526 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 28.4 t70 -90.97 -55.0 3.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.75 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 15.4 pttm -155.32 -123.53 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.768 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.22 -65.84 0.97 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.231 0.539 . . . . 0.0 110.908 176.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.406 ' HA ' ' H ' ' A' ' 17' ' ' SER . 36.5 m -136.9 155.47 49.72 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -175.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.486 HD11 ' H ' ' A' ' 15' ' ' ARG . 0.8 OUTLIER -85.97 -14.53 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -175.364 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.66 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 52.08 47.45 24.73 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.082 -176.353 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HG2' ' HB ' ' A' ' 24' ' ' ILE . 74.3 mmtt -80.82 62.61 4.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.139 0.495 . . . . 0.0 110.267 175.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.338 -0.839 . . . . 0.0 109.807 -178.942 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.888 0.375 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -144.17 159.36 42.77 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 6' ' ' ASN . 10.2 p30 -147.9 151.08 37.57 Favored Pre-proline 0 C--N 1.322 -0.63 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.063 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.4 ' HD2' ' OD1' ' A' ' 6' ' ' ASN . 2.8 Cg_exo -75.56 -53.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.438 2.092 . . . . 0.0 111.159 171.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.4 t -152.23 32.86 0.52 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.552 0.691 . . . . 0.0 110.175 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 3' ' ' ASN . 1.6 m-20 -92.31 24.32 3.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.52 -177.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.59 141.88 8.3 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.9 t -79.77 81.05 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.48 0.657 . . . . 0.0 110.487 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 t -115.11 31.35 6.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 122.232 1.015 . . . . 0.0 109.214 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.3 m -140.76 140.06 21.18 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.533 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.478 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 15.0 Cg_endo -56.54 -25.29 57.97 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 124.186 3.257 . . . . 0.0 112.893 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.7 m -139.45 155.58 47.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.394 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.4 45.16 3.34 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.351 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.728 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -80.02 -96.7 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.436 -0.106 . . . . 0.0 111.221 177.294 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.418 ' H ' HD11 ' A' ' 24' ' ' ILE . 71.9 mtm180 -137.62 130.62 30.37 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.195 0.522 . . . . 0.0 111.06 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.441 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 22.5 m -86.62 84.92 7.3 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.678 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.491 ' CB ' HG23 ' A' ' 24' ' ' ILE . 26.5 p -78.99 44.62 0.57 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.721 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.6 mm -64.32 -18.3 22.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 121.722 0.772 . . . . 0.0 110.329 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 m -78.24 -33.37 17.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.415 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -87.93 -52.91 5.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.421 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -160.94 -127.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.338 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -83.23 -134.81 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.455 ' SG ' ' HE1' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -94.31 154.66 17.39 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.491 HG23 ' CB ' ' A' ' 17' ' ' SER . 1.6 pp -79.65 -9.49 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -168.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.728 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 1.9 mptm? 43.74 60.74 2.55 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 24' ' ' ILE . 47.0 mmtm -125.53 51.99 1.67 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.92 0.391 . . . . 0.0 111.057 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.545 176.672 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 98.6 mt . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.827 0.346 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -95.02 47.04 1.13 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.182 0.515 . . . . 0.0 110.512 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -67.88 153.88 94.5 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.054 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.46 72.4 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.193 2.595 . . . . 0.0 113.304 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 16' ' ' CYS . 3.6 t -81.15 -45.45 16.37 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 54.34 56.44 6.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.529 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.94 121.23 1.01 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.418 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.9 m -91.19 -22.0 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.186 0.517 . . . . 0.0 110.59 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 m -88.18 75.61 8.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.885 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.437 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 68.9 m -151.34 111.22 3.01 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.618 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.547 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 18.6 Cg_endo -58.49 -31.51 94.43 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.189 2.593 . . . . 0.0 112.57 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.484 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 24.0 m -126.18 160.38 30.38 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.64 48.62 3.08 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.549 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.579 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -84.38 -97.74 0.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.469 0.174 . . . . 0.0 111.469 177.357 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.444 ' O ' HG13 ' A' ' 24' ' ' ILE . 77.7 mtm180 -136.0 133.47 37.53 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.5 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 57.0 m -86.2 93.21 8.99 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.651 -171.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.71 ' HB2' HG23 ' A' ' 24' ' ' ILE . 7.8 t -79.94 47.82 0.91 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.304 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 42.2 mm -66.08 -17.44 22.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.76 0.79 . . . . 0.0 109.832 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 19' ' ' VAL . 4.4 m -77.95 -35.34 20.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.894 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -91.47 -49.57 6.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.16 0.505 . . . . 0.0 110.676 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.529 ' HE3' ' O ' ' A' ' 23' ' ' CYS . 47.5 pttt -157.02 -121.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.804 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.423 ' HG3' ' H ' ' A' ' 23' ' ' CYS . 5.9 pt20 -91.66 -70.98 0.66 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.459 -0.151 . . . . 0.0 111.177 173.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.529 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -148.2 166.05 29.1 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.025 -0.422 . . . . 0.0 110.406 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.71 HG23 ' HB2' ' A' ' 17' ' ' SER . 1.4 pp -91.15 -3.58 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -167.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 3.6 mmmp? 51.93 31.77 9.0 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 177.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.433 ' HB2' HD13 ' A' ' 24' ' ' ILE . 48.1 mmtm -111.9 85.73 2.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.118 0.485 . . . . 0.0 110.056 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 . . . . . 0 C--O 1.25 1.09 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.263 -176.779 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 121.251 0.548 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -101.97 22.16 13.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.355 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.517 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 26.0 t-20 -57.41 -53.26 67.31 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 3' ' ' ASN . 9.6 Cg_endo -91.44 49.06 0.66 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.615 2.21 . . . . 0.0 112.415 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.0 t -172.45 131.59 0.59 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.066 0.46 . . . . 0.0 110.9 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -122.29 2.08 9.7 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.883 0.849 . . . . 0.0 109.714 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.86 98.41 0.18 Allowed Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.018 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.8 t -76.37 77.42 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.429 0.633 . . . . 0.0 111.293 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.7 t -99.33 25.05 7.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.331 1.063 . . . . 0.0 108.992 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 18.6 m -107.07 140.83 21.8 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.795 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.94 -27.2 84.38 Favored 'Trans proline' 0 N--CA 1.474 0.328 0 C-N-CA 124.08 3.187 . . . . 0.0 112.912 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.0 t -134.47 158.27 44.35 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.55 46.98 3.54 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.083 -173.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.571 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -82.43 -102.71 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.975 174.705 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.483 ' HG3' HG12 ' A' ' 24' ' ' ILE . 15.9 ptm180 -143.63 159.14 42.99 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.3 m -106.92 93.35 4.51 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.46 ' CB ' HG23 ' A' ' 24' ' ' ILE . 4.8 p -79.9 42.8 0.56 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.13 -175.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.2 mm -55.13 -19.16 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.427 0.632 . . . . 0.0 110.909 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.5 m -77.5 -38.18 25.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.767 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.52 ' OD2' ' HD2' ' A' ' 21' ' ' LYS . 37.3 t70 -92.59 -71.02 0.67 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.207 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.52 ' HD2' ' OD2' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -149.3 157.42 43.32 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 172.176 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -38.72 -53.68 1.63 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -165.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.6 m -139.6 146.89 40.36 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.936 -0.477 . . . . 0.0 110.893 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.483 HG12 ' HG3' ' A' ' 15' ' ' ARG . 1.4 pp -84.69 -9.99 11.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -174.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 9.7 mptt 61.47 20.34 11.09 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.441 ' HB2' HD13 ' A' ' 24' ' ' ILE . 14.5 mmmm -98.28 81.6 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.76 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 C--O 1.25 1.112 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.405 178.961 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.711 0.291 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 3' ' ' ASN . 2.4 m-20 -89.51 133.67 34.47 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.478 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 52.1 m-80 67.54 170.47 0.1 Allowed Pre-proline 0 C--O 1.235 0.333 0 O-C-N 123.661 0.601 . . . . 0.0 111.222 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 3' ' ' ASN . 6.1 Cg_endo -50.46 -38.72 54.21 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.468 2.112 . . . . 0.0 111.856 171.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.0 t -123.66 133.94 53.83 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.818 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -111.88 62.25 0.62 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.593 0.711 . . . . 0.0 109.772 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.61 64.73 2.81 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.894 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.6 p -69.83 -16.8 20.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.347 0.594 . . . . 0.0 110.946 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.4 t -122.67 31.03 6.22 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.332 1.063 . . . . 0.0 109.205 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 37.0 m -135.77 142.4 40.54 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.509 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.45 -3.68 6.86 Favored 'Trans proline' 0 N--CA 1.475 0.431 0 C-N-CA 123.527 2.818 . . . . 0.0 113.514 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 t 56.04 32.52 20.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.864 0.84 . . . . 0.0 111.364 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.25 -46.79 3.72 Favored Glycine 0 C--N 1.316 -0.555 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.025 176.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.733 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -91.34 -101.16 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.663 -0.268 . . . . 0.0 111.088 176.223 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.415 ' H ' ' HD1' ' A' ' 14' ' ' TYR . 12.0 ptm180 -161.4 175.43 12.22 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.573 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 3.7 p -109.78 103.24 12.02 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.168 0.508 . . . . 0.0 110.178 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.8 p -79.16 59.87 2.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.044 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 38.7 mm -62.8 -15.94 16.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.789 0.804 . . . . 0.0 110.113 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.7 m -77.5 -34.92 21.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.549 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -91.98 -55.81 3.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.154 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 11.6 pttp -154.79 -126.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.22 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.421 ' HG3' ' H ' ' A' ' 23' ' ' CYS . 8.8 pt20 -91.37 -58.56 2.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 118.422 0.556 . . . . 0.0 111.004 174.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.573 ' SG ' ' HA ' ' A' ' 16' ' ' CYS . 9.4 m -148.67 159.86 43.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.054 0.454 . . . . 0.0 110.378 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.55 ' HB ' ' HG2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -90.89 -11.29 9.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -168.542 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.733 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 31.3 mmmt 55.28 34.72 23.38 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.55 ' HG2' ' HB ' ' A' ' 24' ' ' ILE . 74.9 mmtt -81.04 71.31 8.01 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.24 0.543 . . . . 0.0 110.361 176.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.848 -177.386 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.653 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 10.3 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.945 0.403 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -83.24 13.41 4.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.793 -174.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.66 -77.01 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.996 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.653 ' O ' ' HB2' ' A' ' 5' ' ' CYS . 8.4 p -77.14 159.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.4 m -102.25 117.5 34.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.723 0.296 . . . . 0.0 110.685 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.1 m -79.24 127.28 79.55 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.12 0.486 . . . . 0.0 110.528 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.577 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 19.4 Cg_endo -58.28 -26.58 77.49 Favored 'Trans proline' 0 N--CA 1.474 0.351 0 C-N-CA 124.077 3.185 . . . . 0.0 113.554 -177.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.563 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 23.2 t -131.73 165.12 24.45 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.38 50.54 4.08 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.712 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.748 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -94.94 -118.58 0.1 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 122.735 -0.274 . . . . 0.0 111.447 175.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -134.23 159.14 41.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.09 0.471 . . . . 0.0 110.78 -176.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.3 m -101.08 95.89 6.87 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.582 -173.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.522 ' HB3' HG23 ' A' ' 24' ' ' ILE . 7.9 p -78.95 51.94 1.19 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.54 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 45.3 mm -62.14 -18.7 20.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.242 0.544 . . . . 0.0 111.279 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.22 -36.97 21.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.438 0.637 . . . . 0.0 110.684 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 29.7 t70 -91.09 -48.94 6.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.105 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 15.6 pttm -159.53 -138.81 0.06 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.197 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -92.09 -77.5 0.43 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.172 0.51 . . . . 0.0 110.163 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 77.0 m -121.92 143.24 49.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.377 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.522 HG23 ' HB3' ' A' ' 17' ' ' SER . 1.3 pp -80.05 -15.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -175.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.748 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 13.8 mptt 55.84 29.29 13.77 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.505 ' HD3' ' C ' ' A' ' 26' ' ' LYS . 8.6 tmtm? -91.31 106.11 18.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.218 0.532 . . . . 0.0 109.809 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.44 178.645 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -98.61 136.65 38.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.182 0.515 . . . . 0.0 110.711 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.75 -146.81 4.73 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.647 HG13 ' H ' ' A' ' 9' ' ' THR . 5.9 p -74.27 -63.27 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 117.028 0.414 . . . . 0.0 110.47 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.647 ' H ' HG13 ' A' ' 8' ' ' VAL . 57.2 m -156.18 81.01 0.99 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.068 0.461 . . . . 0.0 110.53 177.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.1 m -124.96 127.65 25.04 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.54 167.24 25.93 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.022 1.815 . . . . 0.0 110.992 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.9 m -94.91 38.08 1.13 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.715 0.769 . . . . 0.0 110.644 -173.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.55 -51.66 2.47 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.451 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.646 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -105.55 -104.54 0.32 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.482 0.179 . . . . 0.0 111.482 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.511 ' H ' HD11 ' A' ' 24' ' ' ILE . 18.2 ptp180 -152.6 169.43 22.68 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.439 ' HB2' HG12 ' A' ' 18' ' ' ILE . 31.8 p -98.19 126.89 43.85 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 t -102.6 40.35 1.38 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.712 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.439 HG12 ' HB2' ' A' ' 16' ' ' CYS . 34.7 mm -62.03 -21.3 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.5 -171.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.0 m -77.7 -37.01 23.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.238 0.542 . . . . 0.0 110.905 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.485 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 11.9 t70 -91.97 -47.03 7.51 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.677 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HG2' ' OD2' ' A' ' 20' ' ' ASP . 15.5 pttm -160.36 -146.52 0.14 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.753 -176.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.455 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 29.1 tt0 -68.89 -85.7 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.338 0.589 . . . . 0.0 111.011 172.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.455 ' SG ' ' HG2' ' A' ' 22' ' ' GLN . 3.2 m -132.64 171.17 14.19 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.511 HD11 ' H ' ' A' ' 15' ' ' ARG . 1.0 OUTLIER -96.7 -13.48 8.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -176.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.646 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 14.5 mptt 55.09 30.93 15.24 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 123.38 0.425 . . . . 0.0 111.651 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -79.31 81.0 5.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.309 -177.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.504 179.437 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 121.375 0.607 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 62.41 27.47 16.35 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.798 171.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.96 -64.7 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.0 t -90.54 135.77 25.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 175.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 m -89.43 105.07 17.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.101 0.476 . . . . 0.0 110.703 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.4 m -80.96 138.94 49.57 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.075 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.481 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 18.0 Cg_endo -58.09 -23.64 62.05 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 124.064 3.176 . . . . 0.0 112.931 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.403 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 41.7 m -136.71 159.86 40.56 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.15 49.01 3.91 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.555 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.768 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -90.45 -105.98 0.09 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.588 0.232 . . . . 0.0 111.516 175.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -132.66 148.47 52.35 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 77.0 m -91.94 111.57 23.16 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.508 ' HB2' HG23 ' A' ' 24' ' ' ILE . 11.5 t -87.05 50.34 2.0 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.121 -174.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.6 mm -65.34 -17.09 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.963 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.3 m -78.39 -38.04 22.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.704 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.454 ' HB2' ' OG ' ' A' ' 17' ' ' SER . 12.9 m-20 -90.98 -67.19 0.87 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.681 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.522 ' HB2' ' H ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -143.2 -124.83 0.09 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.473 -177.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.522 ' H ' ' HB2' ' A' ' 21' ' ' LYS . 20.5 pt20 -93.23 -57.73 2.52 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.975 0.807 . . . . 0.0 111.904 174.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.418 ' N ' ' HG3' ' A' ' 22' ' ' GLN . 60.8 m -139.26 154.44 47.97 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -174.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 17' ' ' SER . 1.0 OUTLIER -87.84 -18.32 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -173.335 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.768 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 46.7 54.75 8.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.895 0.379 . . . . 0.0 110.873 -174.179 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -152.95 128.43 9.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.09 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.55 178.257 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.456 -0.156 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -80.1 57.55 2.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.783 0.801 . . . . 0.0 109.775 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.61 -71.94 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.7 t -91.58 118.53 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.3 m -82.34 130.94 35.21 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.965 0.412 . . . . 0.0 110.794 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.3 m -84.79 153.96 61.11 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.795 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.535 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 6.9 Cg_endo -48.84 -71.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.261 2.641 . . . . 0.0 112.494 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.518 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 33.0 m -86.92 163.28 17.23 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.72 51.68 3.27 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.54 -175.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.786 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -88.32 -100.97 0.08 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 121.343 -0.143 . . . . 0.0 111.349 176.42 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -148.42 153.79 39.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.129 0.49 . . . . 0.0 110.659 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.3 m -93.91 95.61 9.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.161 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.511 ' CB ' HG23 ' A' ' 24' ' ' ILE . 5.6 p -82.11 45.23 0.91 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.115 -177.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.2 mm -56.68 -16.28 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.365 0.602 . . . . 0.0 111.727 -173.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.1 m -77.58 -36.99 23.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.419 0.628 . . . . 0.0 110.139 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -91.04 -74.74 0.49 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.303 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -148.97 160.37 43.35 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -39.36 -57.98 1.3 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -168.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.412 ' SG ' ' HD2' ' A' ' 11' ' ' PRO . 33.7 m -136.38 140.56 43.32 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.529 HD11 ' HB2' ' A' ' 14' ' ' TYR . 1.3 pp -78.86 -16.59 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -175.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.786 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 52.98 35.03 18.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.944 -176.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.451 ' H ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -88.36 101.32 13.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.891 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 121.95 0.881 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -153.27 44.18 0.62 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.5 -174.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.25 -45.22 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.726 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.4 t -90.08 104.34 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.702 0.287 . . . . 0.0 110.462 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.5 m -79.89 90.12 5.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.897 ' SG ' ' HD2' ' A' ' 11' ' ' PRO . 4.5 t -92.17 155.9 42.43 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.125 -172.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.897 ' HD2' ' SG ' ' A' ' 10' ' ' CYS . 7.4 Cg_endo -45.3 -74.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 123.941 3.094 . . . . 0.0 112.873 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.645 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 46.8 t -84.4 150.89 25.03 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.15 52.12 4.32 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.931 -176.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.817 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -81.5 -100.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.816 176.16 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.493 ' H ' HD11 ' A' ' 24' ' ' ILE . 15.3 ptp180 -154.79 160.74 41.49 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.1 p -104.2 104.26 14.15 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.464 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 7.9 p -78.99 59.94 2.79 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.97 -174.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.8 mm -55.01 -18.12 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.278 0.561 . . . . 0.0 111.12 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.8 m -78.59 -39.38 23.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.641 0.734 . . . . 0.0 110.808 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.496 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 16.0 t70 -93.41 -71.21 0.67 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.518 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.496 ' HG2' ' OD2' ' A' ' 20' ' ' ASP . 23.0 pttm -156.75 178.1 10.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.502 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -46.02 -49.21 16.43 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 65.6 m -149.74 154.51 38.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.268 0.556 . . . . 0.0 110.211 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.493 HD11 ' H ' ' A' ' 15' ' ' ARG . 0.8 OUTLIER -90.04 -25.25 5.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.814 -173.122 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.817 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 53.71 37.92 27.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.887 -171.079 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.409 ' H ' HD13 ' A' ' 24' ' ' ILE . 75.7 mmtt -117.16 171.95 7.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.666 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.003 179.156 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.1 t . . . . . 0 C--O 1.236 0.356 0 CA-C-O 121.151 0.5 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -155.62 66.86 0.62 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.327 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.5 -83.44 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.388 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -73.48 120.47 22.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.9 m -79.55 109.19 13.69 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.351 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.2 m -79.88 139.69 53.94 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.008 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 13.3 Cg_endo -55.8 -69.42 0.05 OUTLIER 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.929 2.419 . . . . 0.0 112.425 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.459 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 3.4 m -81.61 165.97 20.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.242 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.17 45.3 2.99 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.93 -174.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.66 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -89.03 -104.44 0.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.557 0.218 . . . . 0.0 111.336 177.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.486 ' H ' HD11 ' A' ' 24' ' ' ILE . 2.0 ptm180 -148.25 156.26 42.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.888 0.375 . . . . 0.0 110.517 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.2 m -89.32 108.45 19.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.768 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.484 ' HB2' HG23 ' A' ' 24' ' ' ILE . 5.8 t -82.63 52.77 2.17 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 30.9 mm -64.99 -16.06 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.378 0.609 . . . . 0.0 110.593 -175.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 m -78.06 -36.99 22.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.526 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 28.4 t70 -90.97 -55.0 3.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.75 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 15.4 pttm -155.32 -123.53 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.768 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.22 -65.84 0.97 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.231 0.539 . . . . 0.0 110.908 176.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.406 ' HA ' ' H ' ' A' ' 17' ' ' SER . 36.5 m -136.9 155.47 49.72 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -175.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.486 HD11 ' H ' ' A' ' 15' ' ' ARG . 0.8 OUTLIER -85.97 -14.53 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -175.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.66 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 52.08 47.45 24.73 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.082 -176.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HG2' ' HB ' ' A' ' 24' ' ' ILE . 74.3 mmtt -80.82 62.61 4.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.139 0.495 . . . . 0.0 110.267 175.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.338 -0.839 . . . . 0.0 109.807 -178.942 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.4 t . . . . . 0 C--O 1.233 0.203 0 CA-C-O 121.552 0.691 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -92.31 24.32 3.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.52 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.59 141.88 8.3 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.9 t -79.77 81.05 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.48 0.657 . . . . 0.0 110.487 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 t -115.11 31.35 6.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 122.232 1.015 . . . . 0.0 109.214 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.3 m -140.76 140.06 21.18 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.533 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.478 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 15.0 Cg_endo -56.54 -25.29 57.97 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 124.186 3.257 . . . . 0.0 112.893 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.7 m -139.45 155.58 47.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.394 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.4 45.16 3.34 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.351 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.728 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -80.02 -96.7 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.436 -0.106 . . . . 0.0 111.221 177.294 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.418 ' H ' HD11 ' A' ' 24' ' ' ILE . 71.9 mtm180 -137.62 130.62 30.37 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.195 0.522 . . . . 0.0 111.06 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.441 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 22.5 m -86.62 84.92 7.3 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.678 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.491 ' CB ' HG23 ' A' ' 24' ' ' ILE . 26.5 p -78.99 44.62 0.57 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.721 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.6 mm -64.32 -18.3 22.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 121.722 0.772 . . . . 0.0 110.329 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 m -78.24 -33.37 17.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.415 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -87.93 -52.91 5.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.421 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -160.94 -127.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.338 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -83.23 -134.81 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.455 ' SG ' ' HE1' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -94.31 154.66 17.39 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.491 HG23 ' CB ' ' A' ' 17' ' ' SER . 1.6 pp -79.65 -9.49 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -168.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.728 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 1.9 mptm? 43.74 60.74 2.55 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 24' ' ' ILE . 47.0 mmtm -125.53 51.99 1.67 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.92 0.391 . . . . 0.0 111.057 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.545 176.672 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 16' ' ' CYS . 3.6 t . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 54.34 56.44 6.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.529 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.94 121.23 1.01 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.418 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.9 m -91.19 -22.0 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.186 0.517 . . . . 0.0 110.59 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 m -88.18 75.61 8.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.885 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.437 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 68.9 m -151.34 111.22 3.01 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.618 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.547 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 18.6 Cg_endo -58.49 -31.51 94.43 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.189 2.593 . . . . 0.0 112.57 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.484 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 24.0 m -126.18 160.38 30.38 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.64 48.62 3.08 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.549 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.579 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -84.38 -97.74 0.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.469 0.174 . . . . 0.0 111.469 177.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.444 ' O ' HG13 ' A' ' 24' ' ' ILE . 77.7 mtm180 -136.0 133.47 37.53 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.5 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 57.0 m -86.2 93.21 8.99 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.651 -171.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.71 ' HB2' HG23 ' A' ' 24' ' ' ILE . 7.8 t -79.94 47.82 0.91 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.304 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 42.2 mm -66.08 -17.44 22.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.76 0.79 . . . . 0.0 109.832 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 19' ' ' VAL . 4.4 m -77.95 -35.34 20.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.894 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -91.47 -49.57 6.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.16 0.505 . . . . 0.0 110.676 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.529 ' HE3' ' O ' ' A' ' 23' ' ' CYS . 47.5 pttt -157.02 -121.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.804 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.423 ' HG3' ' H ' ' A' ' 23' ' ' CYS . 5.9 pt20 -91.66 -70.98 0.66 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.459 -0.151 . . . . 0.0 111.177 173.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.529 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -148.2 166.05 29.1 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.025 -0.422 . . . . 0.0 110.406 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.71 HG23 ' HB2' ' A' ' 17' ' ' SER . 1.4 pp -91.15 -3.58 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -167.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 3.6 mmmp? 51.93 31.77 9.0 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 177.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.433 ' HB2' HD13 ' A' ' 24' ' ' ILE . 48.1 mmtm -111.9 85.73 2.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.118 0.485 . . . . 0.0 110.056 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 . . . . . 0 C--O 1.25 1.09 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.263 -176.779 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.0 t . . . . . 0 N--CA 1.458 -0.047 0 CA-C-O 121.066 0.46 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -122.29 2.08 9.7 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.883 0.849 . . . . 0.0 109.714 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.86 98.41 0.18 Allowed Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.018 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.8 t -76.37 77.42 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.429 0.633 . . . . 0.0 111.293 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.7 t -99.33 25.05 7.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.331 1.063 . . . . 0.0 108.992 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 18.6 m -107.07 140.83 21.8 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.795 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.94 -27.2 84.38 Favored 'Trans proline' 0 N--CA 1.474 0.328 0 C-N-CA 124.08 3.187 . . . . 0.0 112.912 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.0 t -134.47 158.27 44.35 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.55 46.98 3.54 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.083 -173.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.571 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -82.43 -102.71 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.975 174.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.483 ' HG3' HG12 ' A' ' 24' ' ' ILE . 15.9 ptm180 -143.63 159.14 42.99 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.3 m -106.92 93.35 4.51 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.46 ' CB ' HG23 ' A' ' 24' ' ' ILE . 4.8 p -79.9 42.8 0.56 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.13 -175.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.2 mm -55.13 -19.16 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.427 0.632 . . . . 0.0 110.909 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.5 m -77.5 -38.18 25.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.767 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.52 ' OD2' ' HD2' ' A' ' 21' ' ' LYS . 37.3 t70 -92.59 -71.02 0.67 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.207 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.52 ' HD2' ' OD2' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -149.3 157.42 43.32 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 172.176 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -38.72 -53.68 1.63 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -165.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.6 m -139.6 146.89 40.36 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.936 -0.477 . . . . 0.0 110.893 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.483 HG12 ' HG3' ' A' ' 15' ' ' ARG . 1.4 pp -84.69 -9.99 11.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -174.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 9.7 mptt 61.47 20.34 11.09 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.441 ' HB2' HD13 ' A' ' 24' ' ' ILE . 14.5 mmmm -98.28 81.6 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.76 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 C--O 1.25 1.112 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.405 178.961 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -111.88 62.25 0.62 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.593 0.711 . . . . 0.0 109.772 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.61 64.73 2.81 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.894 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.6 p -69.83 -16.8 20.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.347 0.594 . . . . 0.0 110.946 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.4 t -122.67 31.03 6.22 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.332 1.063 . . . . 0.0 109.205 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 37.0 m -135.77 142.4 40.54 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.509 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.45 -3.68 6.86 Favored 'Trans proline' 0 N--CA 1.475 0.431 0 C-N-CA 123.527 2.818 . . . . 0.0 113.514 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 t 56.04 32.52 20.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.864 0.84 . . . . 0.0 111.364 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.25 -46.79 3.72 Favored Glycine 0 C--N 1.316 -0.555 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.025 176.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.733 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -91.34 -101.16 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.663 -0.268 . . . . 0.0 111.088 176.223 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.415 ' H ' ' HD1' ' A' ' 14' ' ' TYR . 12.0 ptm180 -161.4 175.43 12.22 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.573 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 3.7 p -109.78 103.24 12.02 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.168 0.508 . . . . 0.0 110.178 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.8 p -79.16 59.87 2.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.044 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 38.7 mm -62.8 -15.94 16.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.789 0.804 . . . . 0.0 110.113 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.7 m -77.5 -34.92 21.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.549 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -91.98 -55.81 3.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.154 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 11.6 pttp -154.79 -126.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.22 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.421 ' HG3' ' H ' ' A' ' 23' ' ' CYS . 3.0 pt20 -91.37 -58.56 2.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 118.422 0.556 . . . . 0.0 111.004 174.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.573 ' SG ' ' HA ' ' A' ' 16' ' ' CYS . 9.4 m -148.67 159.86 43.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.054 0.454 . . . . 0.0 110.378 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.55 ' HB ' ' HG2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -90.89 -11.29 9.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -168.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.733 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 31.3 mmmt 55.28 34.72 23.38 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.55 ' HG2' ' HB ' ' A' ' 24' ' ' ILE . 74.9 mmtt -81.04 71.31 8.01 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.24 0.543 . . . . 0.0 110.361 176.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.848 -177.386 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 66.0 tp . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.408 0.147 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -103.15 27.27 7.34 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.559 -174.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.432 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 62.2 t30 -66.78 -50.74 42.96 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 175.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 3' ' ' ASN . 43.3 Cg_endo -69.45 140.98 45.23 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.783 1.655 . . . . 0.0 110.742 168.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.653 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 10.3 m -59.76 137.95 57.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.057 -174.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -83.24 13.41 4.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.793 -174.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.66 -77.01 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.996 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.653 ' O ' ' HB2' ' A' ' 5' ' ' CYS . 8.4 p -77.14 159.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.4 m -102.25 117.5 34.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.723 0.296 . . . . 0.0 110.685 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.1 m -79.24 127.28 79.55 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.12 0.486 . . . . 0.0 110.528 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.577 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 19.4 Cg_endo -58.28 -26.58 77.49 Favored 'Trans proline' 0 N--CA 1.474 0.351 0 C-N-CA 124.077 3.185 . . . . 0.0 113.554 -177.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.563 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 23.2 t -131.73 165.12 24.45 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.38 50.54 4.08 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.712 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.748 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -94.94 -118.58 0.1 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 122.735 -0.274 . . . . 0.0 111.447 175.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -134.23 159.14 41.83 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.09 0.471 . . . . 0.0 110.78 -176.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.3 m -101.08 95.89 6.87 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.582 -173.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.522 ' HB3' HG23 ' A' ' 24' ' ' ILE . 7.9 p -78.95 51.94 1.19 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.54 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 45.3 mm -62.14 -18.7 20.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.242 0.544 . . . . 0.0 111.279 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.8 m -78.22 -36.97 21.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.438 0.637 . . . . 0.0 110.684 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 29.7 t70 -91.09 -48.94 6.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.105 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 15.6 pttm -159.53 -138.81 0.06 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.197 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -92.09 -77.5 0.43 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.172 0.51 . . . . 0.0 110.163 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 77.0 m -121.92 143.24 49.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.377 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.522 HG23 ' HB3' ' A' ' 17' ' ' SER . 1.3 pp -80.05 -15.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -175.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.748 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 13.8 mptt 55.84 29.29 13.77 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.505 ' HD3' ' C ' ' A' ' 26' ' ' LYS . 8.6 tmtm? -91.31 106.11 18.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.218 0.532 . . . . 0.0 109.809 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.44 178.645 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 12' ' ' SER . 6.8 t30 58.4 63.13 1.79 Allowed 'General case' 0 N--CA 1.463 0.201 0 O-C-N 123.621 0.576 . . . . 0.0 110.608 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -103.87 106.14 51.43 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.171 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -74.48 68.26 5.32 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.99 2.46 . . . . 0.0 111.651 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.3 t -93.89 145.93 24.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.201 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -98.61 136.65 38.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.182 0.515 . . . . 0.0 110.711 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.75 -146.81 4.73 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.647 HG13 ' H ' ' A' ' 9' ' ' THR . 5.9 p -74.27 -63.27 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 117.028 0.414 . . . . 0.0 110.47 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.647 ' H ' HG13 ' A' ' 8' ' ' VAL . 57.2 m -156.18 81.01 0.99 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.068 0.461 . . . . 0.0 110.53 177.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.1 m -124.96 127.65 25.04 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 173.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.54 167.24 25.93 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.022 1.815 . . . . 0.0 110.992 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 20.9 m -94.91 38.08 1.13 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.715 0.769 . . . . 0.0 110.644 -173.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.55 -51.66 2.47 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.451 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.646 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -105.55 -104.54 0.32 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.482 0.179 . . . . 0.0 111.482 -179.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.511 ' H ' HD11 ' A' ' 24' ' ' ILE . 18.2 ptp180 -152.6 169.43 22.68 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.439 ' HB2' HG12 ' A' ' 18' ' ' ILE . 31.8 p -98.19 126.89 43.85 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 t -102.6 40.35 1.38 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.712 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.439 HG12 ' HB2' ' A' ' 16' ' ' CYS . 34.7 mm -62.03 -21.3 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.5 -171.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.0 m -77.7 -37.01 23.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.238 0.542 . . . . 0.0 110.905 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.485 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 11.9 t70 -91.97 -47.03 7.51 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.677 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HG2' ' OD2' ' A' ' 20' ' ' ASP . 15.5 pttm -160.36 -146.52 0.14 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.753 -176.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.455 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 29.1 tt0 -68.89 -85.7 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.338 0.589 . . . . 0.0 111.011 172.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.455 ' SG ' ' HG2' ' A' ' 22' ' ' GLN . 3.2 m -132.64 171.17 14.19 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.511 HD11 ' H ' ' A' ' 15' ' ' ARG . 1.0 OUTLIER -96.7 -13.48 8.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -176.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.646 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 14.5 mptt 55.09 30.93 15.24 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 123.38 0.425 . . . . 0.0 111.651 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -79.31 81.0 5.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.309 -177.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.504 179.437 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -128.14 86.14 2.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.264 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -128.1 78.01 75.95 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 120.957 0.408 . . . . 0.0 110.703 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.68 93.55 1.02 Allowed 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.543 2.162 . . . . 0.0 112.037 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.4 p -74.82 -25.11 58.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.375 0.607 . . . . 0.0 110.325 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 62.41 27.47 16.35 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.798 171.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.96 -64.7 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.0 t -90.54 135.77 25.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 175.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 m -89.43 105.07 17.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.101 0.476 . . . . 0.0 110.703 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.4 m -80.96 138.94 49.57 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.075 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.481 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 18.0 Cg_endo -58.09 -23.64 62.05 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 124.064 3.176 . . . . 0.0 112.931 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.403 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 41.7 m -136.71 159.86 40.56 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.15 49.01 3.91 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.555 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.768 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -90.45 -105.98 0.09 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.588 0.232 . . . . 0.0 111.516 175.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -132.66 148.47 52.35 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 77.0 m -91.94 111.57 23.16 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.508 ' HB2' HG23 ' A' ' 24' ' ' ILE . 11.5 t -87.05 50.34 2.0 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.121 -174.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.6 mm -65.34 -17.09 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.963 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.3 m -78.39 -38.04 22.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.704 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.454 ' HB2' ' OG ' ' A' ' 17' ' ' SER . 12.9 m-20 -90.98 -67.19 0.87 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.681 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.522 ' HB2' ' H ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -143.2 -124.83 0.09 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.473 -177.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.522 ' H ' ' HB2' ' A' ' 21' ' ' LYS . 20.5 pt20 -93.23 -57.73 2.52 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.975 0.807 . . . . 0.0 111.904 174.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.418 ' N ' ' HG3' ' A' ' 22' ' ' GLN . 60.8 m -139.26 154.44 47.97 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -174.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 17' ' ' SER . 1.0 OUTLIER -87.84 -18.32 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -173.335 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.768 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 46.7 54.75 8.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.895 0.379 . . . . 0.0 110.873 -174.179 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -152.95 128.43 9.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.09 -176.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.55 178.257 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 120.707 0.289 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -66.25 137.59 57.06 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.165 0.507 . . . . 0.0 111.091 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -130.86 150.31 76.17 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.887 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.41 172.86 14.63 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.5 2.133 . . . . 0.0 111.439 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 30.1 t -66.7 -29.8 69.88 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -80.1 57.55 2.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.783 0.801 . . . . 0.0 109.775 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.61 -71.94 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.7 t -91.58 118.53 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.3 m -82.34 130.94 35.21 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.965 0.412 . . . . 0.0 110.794 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.3 m -84.79 153.96 61.11 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.795 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.535 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 6.9 Cg_endo -48.84 -71.73 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.261 2.641 . . . . 0.0 112.494 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.518 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 33.0 m -86.92 163.28 17.23 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 177.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.72 51.68 3.27 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.54 -175.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.786 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -88.32 -100.97 0.08 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 121.343 -0.143 . . . . 0.0 111.349 176.42 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -148.42 153.79 39.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.129 0.49 . . . . 0.0 110.659 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.3 m -93.91 95.61 9.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.161 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.511 ' CB ' HG23 ' A' ' 24' ' ' ILE . 5.6 p -82.11 45.23 0.91 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.115 -177.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.2 mm -56.68 -16.28 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.365 0.602 . . . . 0.0 111.727 -173.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.1 m -77.58 -36.99 23.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.419 0.628 . . . . 0.0 110.139 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -91.04 -74.74 0.49 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.303 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -148.97 160.37 43.35 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -39.36 -57.98 1.3 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -168.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.412 ' SG ' ' HD2' ' A' ' 11' ' ' PRO . 33.7 m -136.38 140.56 43.32 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.529 HD11 ' HB2' ' A' ' 14' ' ' TYR . 1.3 pp -78.86 -16.59 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -175.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.786 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 52.98 35.03 18.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.944 -176.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.451 ' H ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -88.36 101.32 13.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.891 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.397 0.141 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 58.2 t30 57.61 65.25 1.37 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.694 0.759 . . . . 0.0 109.653 -176.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -126.9 100.55 27.5 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.422 -176.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.38 0.95 9.26 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.979 2.453 . . . . 0.0 111.128 174.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.7 t 71.04 118.57 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.245 -1.343 . . . . 0.0 110.837 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -153.27 44.18 0.62 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.5 -174.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.25 -45.22 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.726 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.4 t -90.08 104.34 15.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.702 0.287 . . . . 0.0 110.462 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.5 m -79.89 90.12 5.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.897 ' SG ' ' HD2' ' A' ' 11' ' ' PRO . 4.5 t -92.17 155.9 42.43 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.125 -172.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.897 ' HD2' ' SG ' ' A' ' 10' ' ' CYS . 7.4 Cg_endo -45.3 -74.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 123.941 3.094 . . . . 0.0 112.873 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.645 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 46.8 t -84.4 150.89 25.03 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.15 52.12 4.32 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.931 -176.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.817 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -81.5 -100.74 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.816 176.16 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.493 ' H ' HD11 ' A' ' 24' ' ' ILE . 15.3 ptp180 -154.79 160.74 41.49 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 177.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.1 p -104.2 104.26 14.15 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.464 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 7.9 p -78.99 59.94 2.79 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.97 -174.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.8 mm -55.01 -18.12 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.278 0.561 . . . . 0.0 111.12 -176.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.8 m -78.59 -39.38 23.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.641 0.734 . . . . 0.0 110.808 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.496 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 16.0 t70 -93.41 -71.21 0.67 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.518 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.496 ' HG2' ' OD2' ' A' ' 20' ' ' ASP . 23.0 pttm -156.75 178.1 10.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.502 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -46.02 -49.21 16.43 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 65.6 m -149.74 154.51 38.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.268 0.556 . . . . 0.0 110.211 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.493 HD11 ' H ' ' A' ' 15' ' ' ARG . 0.8 OUTLIER -90.04 -25.25 5.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.814 -173.122 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.817 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 53.71 37.92 27.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.887 -171.079 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.409 ' H ' HD13 ' A' ' 24' ' ' ILE . 75.7 mmtt -117.16 171.95 7.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.666 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.003 179.156 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 93.0 mt . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 121.181 0.515 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -127.77 34.09 4.69 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -100.26 152.86 37.95 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.291 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.95 141.67 55.54 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.044 2.496 . . . . 0.0 111.823 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.1 t -65.18 124.67 22.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.151 0.5 . . . . 0.0 111.812 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -155.62 66.86 0.62 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.327 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.5 -83.44 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.388 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -73.48 120.47 22.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.9 m -79.55 109.19 13.69 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.351 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.2 m -79.88 139.69 53.94 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.008 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 13.3 Cg_endo -55.8 -69.42 0.05 OUTLIER 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.929 2.419 . . . . 0.0 112.425 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.459 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 3.4 m -81.61 165.97 20.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.242 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.17 45.3 2.99 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.93 -174.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.66 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -89.03 -104.44 0.09 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.557 0.218 . . . . 0.0 111.336 177.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.486 ' H ' HD11 ' A' ' 24' ' ' ILE . 2.0 ptm180 -148.25 156.26 42.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.888 0.375 . . . . 0.0 110.517 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.2 m -89.32 108.45 19.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.768 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.484 ' HB2' HG23 ' A' ' 24' ' ' ILE . 5.8 t -82.63 52.77 2.17 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 30.9 mm -64.99 -16.06 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 121.378 0.609 . . . . 0.0 110.593 -175.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 m -78.06 -36.99 22.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.526 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD2' ' HG2' ' A' ' 21' ' ' LYS . 28.4 t70 -90.97 -55.0 3.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.75 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 15.4 pttm -155.32 -123.53 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.768 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.22 -65.84 0.97 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.231 0.539 . . . . 0.0 110.908 176.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.406 ' HA ' ' H ' ' A' ' 17' ' ' SER . 36.5 m -136.9 155.47 49.72 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -175.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.486 HD11 ' H ' ' A' ' 15' ' ' ARG . 0.8 OUTLIER -85.97 -14.53 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -175.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.66 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 52.08 47.45 24.73 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.082 -176.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HG2' ' HB ' ' A' ' 24' ' ' ILE . 74.3 mmtt -80.82 62.61 4.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.139 0.495 . . . . 0.0 110.267 175.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.338 -0.839 . . . . 0.0 109.807 -178.942 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.888 0.375 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -144.17 159.36 42.77 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 6' ' ' ASN . 10.2 p30 -147.9 151.08 37.57 Favored Pre-proline 0 C--N 1.322 -0.63 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.063 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.4 ' HD2' ' OD1' ' A' ' 6' ' ' ASN . 2.8 Cg_exo -75.56 -53.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.438 2.092 . . . . 0.0 111.159 171.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.4 t -152.23 32.86 0.52 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.552 0.691 . . . . 0.0 110.175 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 3' ' ' ASN . 1.6 m-20 -92.31 24.32 3.45 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.52 -177.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.59 141.88 8.3 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.9 t -79.77 81.05 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.48 0.657 . . . . 0.0 110.487 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 t -115.11 31.35 6.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 122.232 1.015 . . . . 0.0 109.214 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.3 m -140.76 140.06 21.18 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.533 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.478 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 15.0 Cg_endo -56.54 -25.29 57.97 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 124.186 3.257 . . . . 0.0 112.893 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.7 m -139.45 155.58 47.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.394 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.4 45.16 3.34 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.351 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.728 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -80.02 -96.7 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.436 -0.106 . . . . 0.0 111.221 177.294 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.418 ' H ' HD11 ' A' ' 24' ' ' ILE . 71.9 mtm180 -137.62 130.62 30.37 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.195 0.522 . . . . 0.0 111.06 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.441 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 22.5 m -86.62 84.92 7.3 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.678 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.491 ' CB ' HG23 ' A' ' 24' ' ' ILE . 26.5 p -78.99 44.62 0.57 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.721 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.6 mm -64.32 -18.3 22.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 121.722 0.772 . . . . 0.0 110.329 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.7 m -78.24 -33.37 17.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.415 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -87.93 -52.91 5.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.421 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -160.94 -127.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.338 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -83.23 -134.81 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.455 ' SG ' ' HE1' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -94.31 154.66 17.39 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.491 HG23 ' CB ' ' A' ' 17' ' ' SER . 1.6 pp -79.65 -9.49 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -168.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.728 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 1.9 mptm? 43.74 60.74 2.55 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 24' ' ' ILE . 47.0 mmtm -125.53 51.99 1.67 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.92 0.391 . . . . 0.0 111.057 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.545 176.672 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 98.6 mt . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 120.827 0.346 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -95.02 47.04 1.13 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.182 0.515 . . . . 0.0 110.512 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -67.88 153.88 94.5 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.054 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.46 72.4 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.193 2.595 . . . . 0.0 113.304 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 16' ' ' CYS . 3.6 t -81.15 -45.45 16.37 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 54.34 56.44 6.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.529 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.94 121.23 1.01 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.418 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.9 m -91.19 -22.0 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.186 0.517 . . . . 0.0 110.59 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 m -88.18 75.61 8.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.885 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.437 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . 68.9 m -151.34 111.22 3.01 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.618 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.547 ' HG2' ' OH ' ' A' ' 14' ' ' TYR . 18.6 Cg_endo -58.49 -31.51 94.43 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.189 2.593 . . . . 0.0 112.57 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.484 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 24.0 m -126.18 160.38 30.38 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.64 48.62 3.08 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.549 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.579 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -84.38 -97.74 0.06 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.469 0.174 . . . . 0.0 111.469 177.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.444 ' O ' HG13 ' A' ' 24' ' ' ILE . 77.7 mtm180 -136.0 133.47 37.53 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.5 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 57.0 m -86.2 93.21 8.99 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.651 -171.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.71 ' HB2' HG23 ' A' ' 24' ' ' ILE . 7.8 t -79.94 47.82 0.91 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.304 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 42.2 mm -66.08 -17.44 22.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 121.76 0.79 . . . . 0.0 109.832 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 19' ' ' VAL . 4.4 m -77.95 -35.34 20.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.894 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -91.47 -49.57 6.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.16 0.505 . . . . 0.0 110.676 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.529 ' HE3' ' O ' ' A' ' 23' ' ' CYS . 47.5 pttt -157.02 -121.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.804 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.423 ' HG3' ' H ' ' A' ' 23' ' ' CYS . 5.9 pt20 -91.66 -70.98 0.66 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.459 -0.151 . . . . 0.0 111.177 173.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.529 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -148.2 166.05 29.1 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.025 -0.422 . . . . 0.0 110.406 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.71 HG23 ' HB2' ' A' ' 17' ' ' SER . 1.4 pp -91.15 -3.58 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -167.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 3.6 mmmp? 51.93 31.77 9.0 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 177.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.433 ' HB2' HD13 ' A' ' 24' ' ' ILE . 48.1 mmtm -111.9 85.73 2.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.118 0.485 . . . . 0.0 110.056 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 . . . . . 0 C--O 1.25 1.09 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.263 -176.779 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 121.251 0.548 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -101.97 22.16 13.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.355 -176.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.517 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 26.0 t-20 -57.41 -53.26 67.31 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 3' ' ' ASN . 9.6 Cg_endo -91.44 49.06 0.66 Allowed 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.615 2.21 . . . . 0.0 112.415 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 43.0 t -172.45 131.59 0.59 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.066 0.46 . . . . 0.0 110.9 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -122.29 2.08 9.7 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.883 0.849 . . . . 0.0 109.714 175.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.86 98.41 0.18 Allowed Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.018 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.8 t -76.37 77.42 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.429 0.633 . . . . 0.0 111.293 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.7 t -99.33 25.05 7.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.331 1.063 . . . . 0.0 108.992 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 18.6 m -107.07 140.83 21.8 Favored Pre-proline 0 C--N 1.313 -1.019 0 CA-C-N 113.998 -1.455 . . . . 0.0 111.795 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.94 -27.2 84.38 Favored 'Trans proline' 0 N--CA 1.474 0.328 0 C-N-CA 124.08 3.187 . . . . 0.0 112.912 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.0 t -134.47 158.27 44.35 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.55 46.98 3.54 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.083 -173.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.571 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -82.43 -102.71 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.975 174.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.483 ' HG3' HG12 ' A' ' 24' ' ' ILE . 15.9 ptm180 -143.63 159.14 42.99 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 175.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.3 m -106.92 93.35 4.51 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.46 ' CB ' HG23 ' A' ' 24' ' ' ILE . 4.8 p -79.9 42.8 0.56 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.13 -175.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.2 mm -55.13 -19.16 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.427 0.632 . . . . 0.0 110.909 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.5 m -77.5 -38.18 25.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.767 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.52 ' OD2' ' HD2' ' A' ' 21' ' ' LYS . 37.3 t70 -92.59 -71.02 0.67 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.207 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.52 ' HD2' ' OD2' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -149.3 157.42 43.32 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 172.176 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -38.72 -53.68 1.63 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -165.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.6 m -139.6 146.89 40.36 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.936 -0.477 . . . . 0.0 110.893 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.483 HG12 ' HG3' ' A' ' 15' ' ' ARG . 1.4 pp -84.69 -9.99 11.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -174.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 9.7 mptt 61.47 20.34 11.09 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.441 ' HB2' HD13 ' A' ' 24' ' ' ILE . 14.5 mmmm -98.28 81.6 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.76 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 C--O 1.25 1.112 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.405 178.961 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.711 0.291 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 3' ' ' ASN . 2.4 m-20 -89.51 133.67 34.47 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.478 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 52.1 m-80 67.54 170.47 0.1 Allowed Pre-proline 0 C--O 1.235 0.333 0 O-C-N 123.661 0.601 . . . . 0.0 111.222 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 3' ' ' ASN . 6.1 Cg_endo -50.46 -38.72 54.21 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.468 2.112 . . . . 0.0 111.856 171.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.0 t -123.66 133.94 53.83 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.818 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -111.88 62.25 0.62 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.593 0.711 . . . . 0.0 109.772 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.61 64.73 2.81 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.894 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.6 p -69.83 -16.8 20.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.347 0.594 . . . . 0.0 110.946 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.4 t -122.67 31.03 6.22 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 122.332 1.063 . . . . 0.0 109.205 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 37.0 m -135.77 142.4 40.54 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.509 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.45 -3.68 6.86 Favored 'Trans proline' 0 N--CA 1.475 0.431 0 C-N-CA 123.527 2.818 . . . . 0.0 113.514 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 t 56.04 32.52 20.12 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.864 0.84 . . . . 0.0 111.364 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.25 -46.79 3.72 Favored Glycine 0 C--N 1.316 -0.555 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.025 176.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.733 ' CE2' ' HA ' ' A' ' 25' ' ' LYS . 0.2 OUTLIER -91.34 -101.16 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.663 -0.268 . . . . 0.0 111.088 176.223 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.415 ' H ' ' HD1' ' A' ' 14' ' ' TYR . 12.0 ptm180 -161.4 175.43 12.22 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.573 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 3.7 p -109.78 103.24 12.02 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.168 0.508 . . . . 0.0 110.178 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.8 p -79.16 59.87 2.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.044 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 38.7 mm -62.8 -15.94 16.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.789 0.804 . . . . 0.0 110.113 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.7 m -77.5 -34.92 21.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.549 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -91.98 -55.81 3.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.154 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 11.6 pttp -154.79 -126.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.22 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.421 ' HG3' ' H ' ' A' ' 23' ' ' CYS . 3.0 pt20 -91.37 -58.56 2.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 118.422 0.556 . . . . 0.0 111.004 174.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.573 ' SG ' ' HA ' ' A' ' 16' ' ' CYS . 9.4 m -148.67 159.86 43.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.054 0.454 . . . . 0.0 110.378 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.55 ' HB ' ' HG2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -90.89 -11.29 9.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -168.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.733 ' HA ' ' CE2' ' A' ' 14' ' ' TYR . 31.3 mmmt 55.28 34.72 23.38 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.55 ' HG2' ' HB ' ' A' ' 24' ' ' ILE . 74.9 mmtt -81.04 71.31 8.01 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.24 0.543 . . . . 0.0 110.361 176.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.848 -177.386 . . . . . . . . 0 0 . 1 stop_ save_